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ABSTRACT
INTRACELLULAR ZINC TRAFFICKING: AN INTERPLAY OF PROTEOME, METALLOTHIONEIN AND
GLUTATHIONE
by

Afsana Alam Mahim

The University of Wisconsin-Milwaukee, 2020
Under the supervision of Professor David H. Petering
Zinc is the second most abundant transition metal in living organisms. Typically, a eukaryotic
cell contains approximately 3000 zinc binding proteins, in which zinc plays structural or catalytic
roles. Recently, zinc has been reported to have signaling functions as a secondary messenger.
Considering the diverse cellular functions of zinc, the trafficking pathways that help zinc,
following its uptake into cytosol, find the target proteins and generate native Zn-Proteins are
not well-understood. For past few decades, metallothionein, a zinc binding protein with large
stability constants for Zn2+, has been thought of as a mediator in transferring zinc to apoProteins. However, gene knock-outs of metallothionein isoforms, reportedly, do not affect the
birth and survival of metallothionein-null mice, implying that metallothionein is not absolutely
required for zinc trafficking, but may have a supporting role in the process. Beyond
metallothionein, zinc encounters numerous potential zinc binding ligands with varying stability
constants, including the Proteome’s adventitious zinc binding sites and glutathione. In this
research, we characterized the non-specific zinc binding sites of Proteome using a colorimetric
zinc sensor and then investigated if Proteome, metallothionein and glutathione, alone or with
the presence of others, can mediate the transfer of zinc to apo-Proteins to generate native Znii

Proteins. For this, we have used Zn-carbonic anhydrase as a model Zn-Protein, and dansyl
amide as a Zn-carbonic anhydrase sensor. The experimental results indicate that the
mechanism of cellular zinc trafficking leading to the formation of native Zn-Proteins does not
involve the straight-forward transfer of zinc from one particular cellular component or
chaperone to apo-Proteins. Instead, trafficking occurs through a complex interconnected
pathway that primarily includes proteomic non-specific zinc binding sites, metallothionein and
glutathione.
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1. INTRODUCTION
Metal ions play important roles in a plethora of biochemical processes in both prokaryotes and
eukaryotes [1, 2]. In fact, thousands of cellular proteins, named metalloproteins, bind various
metal ions via amino acid side chains containing carboxylate, thiol, and imidazole ligands to
maintain their tertiary or quaternary structures and to perform catalytic functions [3]. Besides
proteins, nucleic acids, such as RNA, require metal ions as well for their structure and function
[4]. The deficiency of these metal ions often results in various biological and pathological
disorders, whereas an excess may turn out to be toxic [1, 2]. Therefore, a proper balance of
intracellular metal ion concentrations and their distribution among organelles and metal
binding sites is very critical and thus tightly regulated by cells [5-7]. Among the biological metal
ions, divalent iron, zinc, copper, calcium, magnesium and manganese ions are present in
detectable amounts (micromolar concentrations) [1, 2].
Zinc is the second most abundant transition metal ion present in living organisms after iron [8].
Under steady state conditions, the intracellular zinc concentration of a eukaryotic cell is in the
range of 100 – 500 µM, mostly bound tightly to thousands of native Zn-proteins, collectively
known as the Zn-Proteome [9, 10]. At physiological pH, conditional stability constants of a few
Zn-proteins have been calculated as between 109 and 1012 M-1 [11, 12]. The steady state
intracellular free zinc concentration is thought to be in the range of pM – nM [8-10, 13].
According to bioinformatic analysis, mammalian cells have approximately 3000 Zn-proteins,
meaning that about 10% of the mammalian proteins require zinc for a wide range of cellular
functions [4, 14]. Since divalent zinc ion has a fully occupied set of d orbitals, it does not
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participate in cellular redox chemistry and, thus, mostly acts either as a structural component
or a catalytical cofactor in Zn-proteins [4, 14-16]. For example, zinc is essential for the threedimensional structures of zinc finger transcription factors, which bind the promoter regions of
DNA and eventually initiate the transcription of many genes [4, 17]. As a catalytic cofactor in
the active sites of enzymes, Zn2+ acts both as a Lewis acid and a binding site to help stabilize the
enzyme-substrate complex [18, 19]. A few of the enzymes that require zinc at their active site
for catalyzing biochemical reactions include carbonic anhydrase, alcohol dehydrogenase, and
alkaline phosphatase.
In the extracellular medium, zinc remains bound mostly to albumin (stability constant 10 7 at pH
7.4), which acts a conduit for zinc into cells [20]. Zinc from extracellular medium is transported
into cell cytosol across plasma membrane by ZIP (Zrt and Irtlike, SLC39A proteins) transporters,
a family of 14 proteins, whereas ZnT transporters, a family of 10 proteins, transport zinc out of
cells and internal organelles (Figure 1) [10, 21-23]. In Figure 1, L represents any zinc-binding
ligand, e.g., albumin, in the case of extracellular medium. The existence of so many zinc
transporter proteins emphasizes the importance of tight regulation of cellular and organelle
zinc levels. The structure of ZIP transporters consists of eight transmembrane helices, whereas
ZnT proteins have six transmembrane helices [22, 24]. Although the transport mechanism of
zinc across plasma membrane at a molecular level is poorly understood, some studies have
reported that transmembrane zinc binding site in a transporter is composed of three aspartate
carboxylates and a histidine imidazole at interface of two helices [25-27].
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Figure 1. Transportation of zinc into and out of cells and internal organelles. [29]

Following the cellular uptake into cytosol by ZIP transporter proteins, zinc eventually binds the
precursor apo-proteins to generate native Zn-proteins. However, the trafficking mechanism
that helps zinc to find its target apo-proteins remains unclear. It has been hypothesized that
zinc follows the similar trafficking mechanism as the well-established copper trafficking
mechanism to find its target proteins [28]. Following the entry into cytosol, copper binds to
specific chaperone proteins that assists in delivering Cu to the specific target protein and
copper is then transferred to the apo-protein via ligand substitution. However, one of the key
differences between cellular copper and zinc is that there are only a small number of copper
proteins, as opposed to about 3000 Zn-proteins. Therefore, it is implausible to assume that cells
have thousands of individual ligand substitution pathways involving chaperone proteins for the
synthesis of 3000 Zn-proteins and thus a chaperone-mediated trafficking mechanism of zinc
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seems unreasonable. Indeed, the fact that inside cells, zinc can potentially bind both specifically
and adventitiously to a plethora of large and small ligands makes the zinc trafficking mechanism
leading to find target proteins complicated [9, 29]. Figure 2 shows the hypothetical zinc
trafficking pathways for the formation of native, specific Zn-proteins.

Figure 2. Hypothetical pathways for zinc trafficking to generate native Zn-proteins. L represents
potential zinc binding ligands, including proteins and small molecules, such as glutathione. [29]

Once inside the cell, zinc can bind to numerous cellular components, including non-specific
binding via amino acid side chains of non-specific proteins [29-31]. The side chains containing
carboxylate, thiolate, and imidazole groups exhibit zinc binding affinity to varying extents [32].
Earlier studies reported that the Proteome is capable of binding excess zinc beyond that
needed for the constitution of native Zn-proteins [29-31, 33]. This characteristic of Proteome
has been termed as zinc buffering capacity by Maret and Krezel [9]. Because of zinc binding
4

affinity of Proteome’s adventitious sites and their abundance in cells, Proteome is a potential
intermediate in zinc trafficking pathways to form native Zn-proteins [29, 31]. According to this
view, after entry into cytosol, zinc binds to adventitious sites of Proteome (L) and eventually
finds target proteins (PN) via ligand substitution (Reaction sequence 1).
Zn2+ + L2  Zn-L2; Zn-L2 + L3 Zn-L3 + L2; Zn-L3 + LK  Zn-LK + L3; Zn-LK + PN  Zn-PN + LK (1)
Moreover, the dissociation of zinc from adventitious sites of Proteome may create a pool of
free zinc that can directly bind apo-Proteins (PN) to make native Zn-Proteins (Zn-PN) [29].
Zn-LK  Zn2+ + LK; PN + Zn2+  Zn-PN

(2)

Metallothionein (MT), a high affinity zinc binding protein, is considered another potential
intermediate in intracellular zinc trafficking [29, 31]. It is a sulfhydryl-rich small protein
containing 20 cysteine residues [34, 35]. In its fully saturated form, metallothionein can bind
seven zinc ions in two thiolate clusters -  domain (Zn4S11) and  domain (Zn3S9) (Figure 3) [34,
36]. The stability constants of MT for zinc ion have been reported in the range of 10 11-12 per zinc
ion [37, 38]. Apart from zinc, it can bind other physiological and toxic metals, including copper,
cadmium, mercury, etc [34, 35, 39, 40]. An elevated uptake of cellular zinc induces the
synthesis of metallothionein [41-44]. Since some of the native Zn-Proteins have comparable
zinc binding constants, e.g. zinc carbonic anhydrase (1011-12) as metallothionein, some studies
have reported metallothionein Is a key player in intracellular zinc trafficking (Reaction 3) [15,
31, 37, 38, 45]. Moreover, cellular electrophiles can react with thiolate ligands of
metallothionein, and, thus, make free zinc available to participate in zinc trafficking [46-51].
Nevertheless, it has been reported that gene knock-outs of metallothionein do not affect the
5

birth and survival of metallothionein-null mice, implying that MT is not absolutely necessary for
cellular zinc trafficking, but may have a supporting role in the process [52].
Zn7-MT + n apo-CA  n Zn-CA + Zn7-n-MT

(3)

Figure 3. Two metal-thiolate clusters of metallothionein -  domain (left) and  domain (right).

Besides its roles as a structural component and catalytic cofactor in the Zn-Proteome, according
to recent studies, zinc can act as a secondary messenger and, thus, as a signaling agent (). For
example, zinc has been reported to participate in dynamic cellular signaling processes, such as
synaptic chemical transmission and endocrine signaling [53, 54]. It is released from synaptic
vesicles of glutamatergic neurons into the synaptic cleft in response to neuronal stimulation
[55-57]. One of the prominent examples of zinc signaling is the upregulation of metallothionein,
when intracellular free zinc concentration is elevated [58, 59]. At increased intracellular zinc
concentration, it binds to and activates the metal response element (MRE)-binding
transcription factor 1 (MTF-1), which in turn binds to MRE sequences of various gene promoters
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and upregulates the synthesis of the corresponding proteins, including metallothionein (MT)
and ZnT1 (Reaction 4 and 5) [60-63]. MT then binds extra intracellular zinc and ZnT1 effluxes
zinc out of the cell, and in the process, cellular zinc homeostasis is maintained [64].
MTF-1 (inactive) + n Zn2+ (high)  Znn-MTF-1 (active)

(4)

Znn-MTF-1 + MRE  Znn-MTF-1•MRE

(5)

The role of zinc as an intracellular signaling agent suggests that besides the large pool of static
zinc that is bound to zinc metallo-proteins, cells have a pool of labile, reactive zinc as well. It has
been suggested that this mobile pool of zinc can be generated from dissociation of zinc from
proteomic ligands (Reaction 6) or can be released from storage vesicles, as some articles have
reported [29, 53-57]. In reaction 6, L represents any zinc binding ligand, including proteins and
other small molecules, such as glutathione.
Zn-L  Zn2+ + L

(6)

Our view is that the labile pool is not free zinc, Zn2+, but, instead, Proteome-bound zinc as
portrayed in reaction sequence 1.
To understand the dynamics and functions of the intracellular mobile zinc pool, the use of
fluorescent/colorimetric sensors as analytical tools has been increasingly popular over the past
couple of decades (Figure 4). These sensors exhibit varying binding affinity for zinc with
apparent dissociation constants at pH 7.4 ranging from micromolar to nanomolar [1, 2, 65-67].
Typically, upon binding zinc, the sensor molecules show an enhancement of
fluorescence/absorbance and/or a shift of wavelength maximum. To study intracellular, mobile
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zinc, cells are usually loaded with a cell-permeable form of the sensor, and the subsequent
change of optical properties of the sensor is interpreted as the response to intracellular zinc
[68-74]. However, the chemistry of these sensors with cellular components remains
understudied. Some are characterized by high zinc binding affinity. It would not be surprising if
these molecules show reactivity with native Zn-proteins or other zinc binding ligands (reaction
7), along with free or labile zinc. Furthermore, some of these probes may form ternary adducts
with zinc bound to Zn-proteins or adventurous sites (Reaction 8).
Zn-Protein + Sensor  apo-Protein + Zn-Sensor

(7)

Zn-Protein + Sensor  Sensor-Zn-Protein

(8)

As shown in Figure 4, 6-methoxy-8-p-toluenesulfonamido-quinoline (TSQ) and its derivative
Zinquin (ZQ) are two of the widely used fluorescent sensors to image intracellular mobile zinc.
They show fluorescence at 490 nm upon forming a 2:1 complex with zinc (Reaction 9) [67, 68,
72-75]. However, it has been reported that under steady state cellular conditions, these two
sensors image predominantly intracellular native Zn-Proteins through ternary complex
formation, not free zinc, as evident from the signature emission maximum of 470 nm (Reaction
10) [76-78].
2 TSQ/ZQ +Zn2+  Zn(TSQ/ZQ)2
TSQ/ZQ + Zn-Protein  TSQ/ZQ-Zn-Protein
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(9)
(10)

Figure 4. Examples of zinc fluorescent sensors.

These sensors compete with other potential zinc binding ligands, e.g., proteome and
glutathione, for intracellular labile zinc, making the cellular chemistry of the sensors more
complicated than typically assumed. For example, Newport Green, a weak zinc fluorescent
sensor with stability constant of 105-6 M, has been used in a number of studies for imaging
intracellular labile zinc [1, 79-84]. However, it has been shown to be outcompeted by high
9

affinity proteomic ligands for intracellular zinc, and, thus, is able to image intracellular zinc, only
when the high affinity proteomic ligands are saturated with zinc [9, 85]. These novel findings of
TSQ, Zinquin and Newport Green reveal that a detailed understanding of the cellular chemistry
of intracellular zinc sensors that are used to study zinc trafficking is as important as that of
understanding cellular zinc trafficking mechanisms.
Herein, we have revisited the zinc buffering study published by Wolfgang Maret research group
using a colorimetric zinc sensor, Zincon, and re-interpreted their results on the basis of our
findings, to better characterize the non-specific zinc binding sites of Proteome and their
interaction with Zincon [9]. Next, we have investigated if the Proteome acts as an intermediate
via its adventitious zinc binding sites for intracellular zinc trafficking leading to the generation of
native Zn-Proteins. In addition, we have studied if metallothionein individually or in cooperation
with Proteome can transfer its strongly bound zinc to apo-proteins. Finally, we have examined if
glutathione plays any role in the overall landscape of intracellular zinc trafficking. For trafficking
studies, we have used zinc carbonic anhydrase (Zn-CA) as a model zinc protein and studied the
reconstitution of Zn-CA mediated by Proteome, metallothionein and glutathione, alone or with
the presence of one another. In conclusion, we have presented a detailed intracellular zinc
trafficking mechanism, starting from cellular uptake of zinc to the formation of native ZnProteins, that involves Proteome, metallothionein and glutathione.
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2. MATERIALS AND METHODS
2.1 Chemicals and Reagents
The zinc fluorescent sensors TSQ and FluoZin-3 were purchased from AnaSpec, Inc. and
Molecular Probes, respectively, and then dissolved in DMSO and stored in the dark at -200 C in
small aliquots. N-ethylmaleimide (NEM), glutathione (GSH), buthionine sulfoximine (BSO),
ethylenediaminetetraacetic acid (EDTA), 5,5’-dithiobis-(2-nitrobenzoic acid (DTNB) and dansyl
amide (DA) were bought from Sigma. Sephadex G-75 and G-25 gel filtration resins were
purchased from GE Healthcare Life Sciences. Metallothionein was obtained from Creative
Biomart, Inc. The model proteins, bovine serum albumin (BSA), trypsin and carbonic anhydrase
were obtained from Sigma in the form of lyophilized powder. The powders were dissolved in
degassed 20 mM Tris buffer adjusted to pH 7.4 and stored at -800 C. The antibiotics penicillin G
and streptomycin sulfate for cell culture were purchased from Fisher Scientific and Sigma,
respectively. Fetal calf serum (FCS) was also bought from Fisher Scientific and stored at -800 C
until use. All the other chemicals and reagents were purchased from either Fisher Scientific or
Sigma-Aldrich at the highest grade available.

2.2. Preparation of medium and solutions for cell culture
LLC-PK1 (pig kidney cells) cell line (adherent cell line) was purchased from ATCC and grown in
Medium 199 with HEPES modification. Medium powder from the bottle was dissolved in 1L
MilliQ water. 2.2 g sodium bicarbonate (NaHCO3) was added to the medium solution and the
pH of the solution was adjusted to 7.2. The medium was then supplemented with 50 mg/L
11

penicillin G and 50 mg/L streptomycin sulfate, and sterile filtered before use. The media
solution was stored in 40 C.
Confluent LLC-PK1 cells were released from the culture flask by 10X trypsin-EDTA treatment. To
prepare 200 mL 10X trypsin-EDTA solution, 1.0 g trypsin, 0.4 g EDTA tetrasodium salt and 1.8 g
sodium chloride (NaCl) were dissolved in MilliQ water. The solution was sterile filtered and
stored in 10 mL aliquots at -200 C.

2.3 Cell culture
LLC-PK1 cells were grown in Medium 199 with HEPES modification supplemented with 2.2 g/L
NaHCO3, 50 mg/L penicillin G, 50 mg/L streptomycin and 4% fetal calf serum (FCS) (from Fischer
Scientific). Each flask of cells contained 15 mL of media mix. The cells were incubated at 37 0 C in
the presence of 5% CO2. The media was changed every 2-3 days until confluence. At the point
of confluence, old media was discarded completely, and cells were released by 10X trypsin
EDTA solution for 10-15 min in the incubator. Once the cells were released, 0.1-0.2 mL cell
suspension was used to make new culture flask and the remaining cells were used for growing
cells in 100-mm culture plates. Each plate contained 10 mL of media mix and 0.4 mL of FCS
along with cells.
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2.4 Cell counting
LLC-PK1 cells were counted using a hemacytometer. The culture medium from one plate of
confluent of cells (ca. 107 cells) was discarded and the cells were then incubated with 450 µL of
10X trypsin-EDTA solution for 10-15 min at 370 C. 1 mL of DPBS was added to the released cells
following trypsin-EDTA incubation. Cells were then transferred to a centrifuge tube containing
550 µL horse serum to make the final volume of 2 mL (450 µL trypsin-EDTA + 1 mL DPBS + 550
µL horse serum) and mixed very well. 10 µL of cells was then transferred to an Eppendorf tube
and diluted to 100 µL using DPBS. 10 µL from the final cell suspension was placed onto a
hemacytometer and the cells were counted. The counted number was finally multiplied by the
dilution factor and the actual number of cells determined.

2.5 Cell viability assay (Trypan blue exclusion assay)
Following incubation with 50 µM ZnCl2 for 48 hours or with 25, 50, 100, 200, 400, 800 and 1600
µM buthionine sulfoximine (BSO) for 24 hours, the culture medium of one plate of LLC-PK1 cells
(ca. 107 cells) was completely drained off and the cells were incubated with 1 mL of 10X trypsinEDTA solution for 10-15 min. The released cells were collected in a centrifuge tube and washed
three times with fresh DPBS and finally resuspended in DPBS. 104 cells were treated with 0.4%
Trypan Blue solution in 1:1 ratio and viable cells were counted immediately using a
hemacytometer. Trypan blue is a dye which can penetrate the compromised cell membrane of
a dead cell and the cell will in turn look blue under the hemacytometer, while the living cells
will appear colorless as Trypan blue is not able to permeate through the cell membrane of an
13

intact cell [86-88]. The cell viability assay was also used with LLC-PK1 cells suspended in culture
medium. As control, the assay protocol was repeated for untreated LLC-PK1 cells.

2.6 Fluorescence spectroscopy of BSO-treated LLC-PK1 cells
LLC-PK1 cells were treated with 100 µM BSO for 24 hours and grown in 100-mm culture plates
until confluence was attained. Culture media from both BSO-treated and untreated (control)
plates was then discarded, and the plates washed three times with cold cholate buffer,
prepared by dissolving 2.47 g Na2HPO4, 0.53 g NaH2PO4, 17.0 g NaCl and 13.33 g choline
chloride in 2 L MilliQ water. Cells were then gently scraped from the plates with a rubber cell
scraper and pooled in Dulbecco’s phosphate buffered saline (DPBS) (0.1 g/L MgCl 2.6H2O, 0.2 g/L
KCl, 0.2 g/L KH2PO4, 8.0 g/L NaCl, 1.15 g/L anhydrous Na2HPO4). Cells were collected by
centrifugation at 680 g for 5 min and resuspended in 10 mL DPBS. The cell suspension was then
transferred to a cuvette and treated with 20 µM TSQ. Then, over a 30 min period and using an
excitation wavelength of 370 nm, emission spectra were recorded between 400 nm and 600 nm
with a Hitachi F-4500 fluorescence spectrophotometer.

2.7 Preparation of Sephadex G-75 and G-25 gel filtration column
Sephadex G-75 beads (4-5 g per gel filtration column) and G-25 beads (10-12 g per column)
purchased from GE Healthcare were soaked in 20 mM Tris buffer (pH 7.4) for 3 hours (G-25
beads) or 24 hours (G-75 beads). Following on, soaked beads were degassed for an hour and
then slowly packed in glass columns to make 0.7 cm x 80 cm Sephadex G-75 and G-25 gel
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filtration columns. G-25 and G-75 columns were washed with degassed 0.2 M phosphate buffer
or 20 mM Tris buffer (pH 7.4), respectively, each time before use.

2.8 Isolation of cell lysate from LLC-PK1 cells
Following incubation of LLC-PK1 cells with 50 µM ZnCl2 for 48 hours or with 100 µM BSO for 24
hours, culture media from both treated and untreated (control) plates was then discarded, and
the plates washed three times with cold cholate buffer. Cells were then gently scraped from
the plates with a rubber cell scraper and pooled in Dulbecco’s phosphate buffered saline
(DPBS). Cells were further washed twice with fresh DPBS and centrifuged each time at 680 g for
5 min to separate the pellet from the extracellular medium. The last cell pellet was
resuspended in 1 mL of cold MilliQ water. Cells were then lysed by sonication and centrifuged
at 47,000 g for 20 min at 4o C to collect the cell supernatant or cell lysate.

2.9 Fractionation of the cell lysate using Sephadex G-75 gel filtration column or Centricon
filtration
The cell lysate collected as above was either loaded onto an 80 cm x 0.75 cm gel filtration
column of Sephadex G-75 (GE Healthcare) equilibrated with 20 mM Tris buffer (pH 7.4) at room
temperature or filtered through a Millipore Centricon Centrifuge filter (3K MW cut off) at 4o C
by centrifugation at 13,000 rpm for 30 min to separate the high and low molecular weight
fractions. During gel-filtration chromatography, the column was eluted with degassed 20 mM
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Tris-Cl (pH 7.4) and 50-60 fractions were collected. The zinc content in each fraction was also
detected by flame atomic absorption spectroscopy (AAS).

2.10 Isolation of Proteome Using Sephadex G-75 Chromatography
LLC-PK1 cells were harvested as described above and finally resuspended in 1 mL cold MilliQ
water. Cells were then lysed by sonication and centrifuged at 47,000 g for 20 min to collect the
cell supernatant, which was then loaded onto a Sephadex G-75 column equilibrated with
degassed 20 mM Tris buffer (pH 7.4). The supernatant was eluted with degassed 20 mM Tris-Cl
(pH 7.4) and 1 mL fractions were collected. Fractions within the high molecular weight region
having absorbance at 280 nm were pooled. These pooled fractions were referred to as the
proteome. Proteome was stored in 1 mL aliquots at -800 C until use. On the day of experiment,
proteome was ice-thawed.

2.11 Reaction of model proteins (bovine serum albumin and trypsin) with Zincon
The solutions of the model Zn-proteins, such as bovine serum albumin, were prepared by
dissolving the lyophilized powder of the Zn-proteins in degassed 20 mM Tris buffer (pH 7.4).
The protein solutions were incubated with Zincon and titrated with zinc. The progress of the
reaction was monitored by recording absorption spectrum. To identify the absorbing species,
the final reaction mixture was fractionated using either Sephadex G-75 gel filtration column or
Centricon filtration. For Sephadex G-75 gel filtration, the sample was eluted with degassed 20
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mM Tris buffer (pH 7.4) and 50-60 fractions were collected. All the fractions were analyzed for
both absorbance, and zinc content using flame atomic absorption spectrophotometry.

2.12 Quantification of zinc
The concentration of Zn2+ in solutions was determined by both flame atomic absorption
spectrophotometry (AAS) and inductively coupled plasma mass spectrometry (ICP-MS).
For measurement by atomic absorption spectrophotometry, a GBC model 904 instrument that
employed an acetylene torch to atomize samples using an 80:20 mixture of compressed air and
acetylene was used. Zinc measurements were made with deuterium background correction.
The instrument was calibrated before each run using three standard Zn2+ solutions of 0.5 ppm,
1.0 ppm and 2.0 ppm. The calibration curve was not considered acceptable until the maximum
error was 0.2 µM or less.
In the case of inductively coupled plasma mass spectrometry (ICP-MS), ICPMS 2030 instrument
was used. Sample and standard solutions were prepared in 2% nitric acid. For calibration curve,
standard zinc solutions of 0.0625, 0.125, 0.25, 0.5, 1.0 and 2.0 ppm were used. A built-in
software, LabSolutions ICPMS (version 1.12), was used for data analysis.

2.13 Quantification of sulfhydryl groups
The concentration of sulfhydryl groups was determined with Ellman’s Reagent or 5, 5’dithiobis2-nitrobenzoic acid (DTNB) [89]. To prepare a 10 mM DTNB stock solution, 25 mL
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MilliQ water was added to 0.1 g DTNB solid. The mixture was gently stirred. Because DTNB is
insoluble at acid pH but oxidizes immediately at pH greater than 8.0, the pH of the solution was
monitored while being stirred. Since the pH was around 3.0 to start out and little DTNB powder
was in solution, a few crystals of Trizma (Tris) base was added until the pH was between 6.5 and
7.0. The solution was then filtered to remove the residual amount of undissolved DTNB. The
filtered DTNB solution was kept into a small brown bottle and stored in dark. The color of the
solution was pale yellow.
For measurement of sulfhydryl concentrations, 60 µL of sample was diluted with 540 µL 20 mM
Tris-Cl, pH 7.4. 60 µL of 10 mM DTNB was then added to the sample and vortexed immediately.
The solution was incubated in dark for 30-60 min before the absorbance at 412 nm was
obtained. An extinction coefficient of 13,600 cm-1M-1 was used to determine the concentration
of reactive thiol groups in the samples.

2.14 Preparation of apo-carbonic anhydrase
Apo-carbonic anhydrase (apo-CA) was prepared according to a published method with some
modification [90, 91]. Namely, 100 mg of the holo enzyme (zinc carbonic anhydrase) was
dissolved in 5 mL of 0.2 M phosphate buffer (pH 7.0), which contained 0.1 M pyridine-2,6dicarboxylic acid (dipicolinic acid). Dipicolinic acid is readily dissolved with the addition of solid
Tris base with constant stirring. Following incubation for 4 hours, the mixture was loaded onto a
Sephadex G-25 gel filtration column and eluted with 10 mM ammonium bicarbonate (NH4HCO3)
at pH 8.6. The eluted fractions were analyzed by determining absorbance at 280 nm and zinc
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concentration using flame atomic absorption spectrophotometry (AAS). The fractions
corresponding to apo-carbonic anhydrase were pooled and stored at -800 C in small aliquots.

2.15 Apo-carbonic anhydrase assay
The concentration of apo-carbonic anhydrase was determined by measuring absorbance at 280
nm using an extinction coefficient,  = 5.7 x 104 M-1 cm-1 [92]. The preparation of apo-carbonic
anhydrase was confirmed by reaction with dansyl amide (DA). DA forms a ternary complex with
native Zn-carbonic anhydrase and exhibits fluorescence at 460 nm but does not react with apocarbonic anhydrase or free zinc [93].

2.16 Denaturation and renaturation of carbonic anhydrase
Apo-carbonic anhydrase solution in 20 mM Tris buffer (pH 7.4) was denatured by guanidinium
hydrochloride. Namely, 100 µM apo-carbonic anhydrase solution was incubated with 4 M
guanidinium hydrochloride, resulting in complete denaturation of apo-CA. In order to renature,
the denatured apo-CA in 4 M guanidinium hydrochloride was 25-fold diluted using 20 mM Tris
buffer (pH 7.4) [94]. Both denaturation and renaturation of apo-carbonic anhydrase were
tested by repeating the protocol with native Zn-CA in the presence of dansyl amide.
Denaturation caused complete loss of dansyl amide fluorescence at 460 nm, that was originally
generated from the formation of ternary complex between dansyl amide and Zn-carbonic
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anhydrase. Renaturation of Zn-carbonic anhydrase returned 460 nm fluorescence of dansyl
amide.

2.17 Ultraviolet-visible spectroscopy
A Beckman Coulter, DU© 640 spectrophotometer was used to measure the absorption spectra
of chromophores in samples or absorbances at their λmax. Measurement of absorbances over
time was used for kinetic studies. One-cm quartz or plastic cuvettes were used for UV (200 -400
nm) and Visible (400 - 700nm) measurements, respectively.
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3. RESULTS
3.1 Characterization of proteome’s non-specific zinc binding
Recent studies have reported that beyond its structural and catalytic role in various proteins,
zinc can act as a secondary messenger in cellular signaling, meaning that cells maintain a mobile
or dynamic zinc pool [53-59]. For example, cellular nitric oxide can react with sulfhydryl groups
of high molecular weight Zn-proteins and thus liberate zinc, which in turn participates in the
downstream cellular processes [33, 95 - 99]. Over the past couple of decades, a number of
colorimetric and fluorescent zinc sensors with a wide range of structures and zinc binding
affinity have been developed to monitor this cellular pool of mobile zinc. Although these
sensors are thought to image only intracellular free zinc, recently published articles concluded
that some of these sensors do not image free zinc in cells. For instance, TSQ and Zinquin (ZQ),
two widely used fluorescent zinc sensors, predominantly image cellular Zn-Proteins, not free
zinc [76-78]. They form ternary complexes with Zn-Proteins, TSQ-Zn-Proteins or ZQ-Zn-Proteins,
characterized by emission maxima at 470 nm, while their binary complexes with free zinc,
Zn(TSQ)2 or Zn(ZQ)2, display an emission maximum at 490 nm [76-78].
2 TSQ/ZQ + Zn2+  Zn(TSQ/ZQ)2 (490 nm)
TSQ/ZQ + Zn-Protein  (TSQ/ZQ)-Zn-Protein (470 nm)

(11)
(12)

Additionally, Newport Green, another fluorescent sensor used to image intracellular free zinc,
was found to be weakly efficient in imaging intracellular free zinc in the proteomic environment
[85]. These interesting findings about some of the zinc sensors question the performance of
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other sensors in sensing intracellular free zinc and thus support the need for re-examination of
the mode of action of these fluorescent probes.
Wolfgang Maret’s research group characterized the proteome’s zinc buffering capacity using
Zincon (ZI), a colorimetric sensor used to image free zinc [9]. ZI has only a modest affinity for
Zn2+ with a stability constant at pH 7.4 of 104.9 [9]. According to their published study, a simple
titration of ZI with Zn2+ resulted in a linear increase of absorbance at 620 nm, indicating the
formation of the Zn-ZI complex. However, when ZI was titrated with Zn2+ in the presence of HT29 cell Proteome, no absorbance at 620 nm was observed until about 2 µM Zn2+ was added,
suggesting that the initially added Zn2+ was bound to some of the Proteome’s non-specific zinc
binding sites, rather than picked up by ZI. Once the proteome’s zinc buffering capacity was
saturated, with the addition of more zinc, the absorbance at 620 nm gradually increased, which
was interpreted as the formation of Zn-ZI complex (Figure 5). However, Maret research group
apparently ignored that the slope of straight line following the initial flat region is not the same
as that of the control line, i.e. titration of ZI with Zn2+ in the absence of Proteome. Therefore, it
cannot represent the simple titration of ZI with Zn2+; at least the altered slope suggests that
Proteome and ZI are competing for Zn2+.
This chapter focuses on re-examining of Maret’s Proteome experiment and re-interpreting the
results of the experiment.
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Figure 5. Spectrophotometric zinc titration of HT-29 cell homogenates after centrifugation at
100,000g in the presence of 200 µM Zincon. Homogenates (500 µL) derived from 6x106 cells
were titrated with zinc sulfate in HEPES-Na, pH 7.4 (open circles). Titration in the absence of
homogenate under the same conditions as control (filled circles). [Krezel et al. (2006), J Biol
Inorg Chem]
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3.1.1 Spectral properties of ZI and Zn-ZI
Zincon (ZI) solution in 20 mM Tris (pH 7.4) showed an absorption maximum at about 490 nm. In
the presence of Zn2+, the absorption maximum shifted to 620 nm (Figure 6A). When 40 µM ZI in
20 mM Tris (pH 7.4) was titrated with Zn2+, its absorbance reached the maximum at equimolar
concentration of Zn2+ (Figure 6 B and C), suggesting that ZI formed a 1:1 complex with Zn2+.
Zn2+ + ZI  Zn-ZI (absorption maximum 620 nm)

(13)

An isosbestic point at 531 nm characterized the reaction, indicative of the straightforward
conversion of ZI into Zn-ZI.
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Figure 6. Spectral properties of ZI and Zn-ZI. (A) Absorption spectrum of 40 µM ZI in 20 mM
Tris (pH 7.4) and the reaction mixture of 40 µM ZI and 40 µM Zn2+. (B) Absorption spectra of
titration of 40 µM ZI with Zn2+. (C) Change of 620 nm absorbance with increasing concentration
of Zn2+.
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3.1.2 Titration of ZI with Zn2+ in the presence of proteome
The titration experiment in the presence of Proteome done by Maret’s research group was
repeated. Proteome containing 4.5 µM native Zn2+ was incubated with 40 µM ZI followed by
the addition of increasing concentrations of added Zn2+. Before the addition of exogenous Zn2+,
ZI displayed an absorption maximum at 490 nm in the presence of Proteome, suggesting that ZI
does not react with native Zn-proteins (Figure 7). No significant change in the absorption
spectrum was observed, until about 10 µM of the extra Zn2+ was added (Figure 7). This initial
unaltered absorbance re-confirmed that the first 10 µM of the added Zn2+ was strongly
buffered by Proteome via its non-specific, high affinity zinc binding sites and that when Zn 2+ was
bound, they were unreactive with ZI. A similar lack of reactivity of Proteome•Zn was observed
at the beginning of the titration of Proteome with Zn 2+ in the presence of Newport Green,
another sensor with low affinity for Zn2+ (stability constant at pH 7.4, 106 [85].
As more Zn2+ was added, the 490 nm absorbance started decreasing. Surprisingly, a concurrent
increase of absorbance at 640 nm, not 620 nm, was observed with the increasing concentration
of added Zn2+ (Figure 7). Moreover, the slope of this straight line plot of absorbance vs. Zn2+
concentration was manifestly different from that of control line. In addition, the quantum yield
was significantly less than that of control titration. Finally, the titration was not characterized by
a precise isosbestic point, indicating that more than two absorbing species were present during
part of the reaction. All these discrepancies clearly indicated that (i) the process was more
complicated than the simple titration of ZI with Zn 2+ as that would yield a slope similar to that
of the control, and (ii) the generated species is not Zn-ZI, as this would show an absorption
maximum at 620 nm. These results conflicted with the interpretation of the Maret research
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group, that claimed the production of the Zn-ZI complex following the saturation of Proteome’s
zinc buffering capacity. The requirement of about 100 µM Zn2+, as opposed to only 40 µM for
the control experiment, for the absorbance to reach its maximum value suggested a possible
competition between Proteome’s non-specific, relatively low affinity zinc binding sites and ZI
for added Zn2+ (reactions 14-16).
To further characterize the absorbing species, in a separate experiment, 50 µM ZI was titrated
with Zn2+ in the presence of Proteome and the final reaction mixture was filtered using a
Centricon 3K molecular weight cut-off filter. Both retentate and filtrate were analyzed for
absorbance and zinc content. Interestingly, almost all of the absorbance and zinc content were
found in the retentate. The absorption spectrum of the retentate was centered at 640 nm
(Figure 8 A). These findings were consistent with the generation of a ternary complex of
Proteome, Zn2+ and ZI, Proteome•Zn-ZI or Proteome(Zn-ZI), in which Zn-ZI binds to Proteome
through the ZI ligand.
Proteome + Zn2+  Proteome•Zn (higher affinity binding sites, buffering region)

(14)

Proteome•Zn + ZI  Proteome•Zn-ZI (lower affinity binding sites, 640 nm absorbance) (15)
Proteome + Zn-ZI  Proteome•Zn-ZI (lower affinity binding sites, 640 nm absorbance) (16)

Finally, the introduction of TPEN, a strong zinc chelator with a conditional stability constant at
pH 7.4 of 1015.6, abolished the 640 nm absorbance and regenerated 490 nm absorbance. The
result of TPEN experiment indicated that the generated ternary complex was Proteome•Zn-ZI.
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However, the unexpected feature of this titration was the fact that instead of being a
stoichiometric ligand exchange reaction, a large excess of TPEN was needed to displace ZI from
Zn2+. Considering that the conditional stability constants of Zn-TPEN and Zn-ZI differ by 1010-11,
the titration results show that Zn2+ in the Proteome•Zn-ZI ternary complex is not readily
accessible to TPEN. (Figure 8 B and C).
Proteome•Zn-ZI + TPEN  Proteome + Zn-TPEN + ZI

(17)

Therefore, this experiment suggested that proteome contains two types of non-specific zinc
binding sites – i) sites with relatively higher affinity for Zn2+ that are unreactive with ZI, and ii)
sites with lower affinity for Zn2+ that permit the binding of Zn2+ to ZI. The proteomic nonspecific zinc binding sites with higher affinity are more important for the Proteome’s zinc
buffering capacity, while other sites permit the formation of ternary complexes with Zn-ZI.
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Figure 7. Titration of ZI with Zn2+ in presence of proteome. (A) Proteome (4.5 µM native Zn2+)
isolated from LLC-PK1 cells was treated with 40 µM ZI followed by titration with Zn2+. The
reaction progress was monitored by recording the absorbance between 350- 700 nm. (B)
Control: change of absorbance at 620 nm with titration of 40 µM ZI with Zn2+. Proteome:
change of absorbance at 640 nm from the titration experiment in presence of proteome.
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Figure 8. Characterization of 640 nm absorbing species. (A) 50 µM ZI was titrated with Zn2+
(final 240 µM) in the presence of Proteome. Thereafter, the final reaction mixture was filtered
using a Centricon 3K molecular weight cut-off filter to separate the high molecular weight and
low molecular weight fractions. (B) Retentate fraction was titrated with TPEN. (C) Change of
640 nm absorbance of the retentate following addition of TPEN.
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3.1.3 Reaction of Proteome•Zn-ZI with TSQ
The formation of ternary complex, Proteome•Zn-ZI, between proteome’s lower affinity zinc
binding sites and Zn-ZI was tested another way. A widely used fluorescent zinc sensor, TSQ
forms ternary complexes with both native Zn-proteins and with zinc that is adventitiously
bound to proteome’s non-specific zinc binding sites [77]. Therefore, the pre-formed ternary
complex Proteome•Zn-ZI was reacted with TSQ to see if it replaces ZI from the ternary complex
and makes new ternary complex, Proteome•Zn-TSQ.
TSQ + Zn-Protein  TSQ-Zn-Protein

(18)

TSQ + Proteome•Zn  Proteome•Zn-TSQ

(19)

For this purpose, first, Proteome•Zn-ZI was formed by titrating 40 µM ZI with Zn2+ in the
presence of isolated proteome. As expected, a gradual increase in absorbance at 640 nm was
observed with the addition of Zn2+ after Proteome’s high affinity zinc binding sites were
saturated, indicating the generation of Proteome•Zn-ZI ternary complex (Figure 9 A and B).
Proteome + Zn-ZI  Proteome•Zn-ZI (640 nm absorbance)

(20)

Subsequently, the final reaction mixture was treated with increasing concentrations of TSQ.
Interestingly, with the increment in TSQ concentration to the reaction mixture, absorbance at
640 nm slowly decreased (Figure 9 C and D). At about 80 µM TSQ, 640 nm absorbance was
almost completely lost. The displacement of ZI from the ternary complex, Proteome•Zn-ZI, by
TSQ and by inference the generation of a new ternary complex, Proteome•Zn-TSQ, was
consistent with the loss of absorbance at 640 nm with addition of TSQ. Since TSQ shows
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negligible absorbance in the 500-650 nm range, the change in the spectrum could be solely
attributed to the dissociation of Zn-ZI in the ternary complex with the Proteome.
Proteome•Zn-ZI + TSQ  Proteome•Zn-TSQ + ZI

(21)

This result further supported that ZI forms ternary complex with zinc adventitiously bound to
proteome’s lower affinity non-specific binding sites
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Figure 9. Reaction of Proteome•Zn-ZI with TSQ. (A) 40 µM ZI was titrated with Zn2+ in the
presence of isolated Proteome. (B) Change of absorbance at 640 nm with the increasing
concentration of added Zn2+. (C) The final reaction mixture of (A) was titrated with TSQ. (D)
Change of absorbance at 640 nm with the increasing concentration of TSQ.
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3.1.4 Reaction of Zn-ZI with a model zinc binding protein
The results of the reaction of Zn2+ and ZI with Proteome were consistent with the formation of
the ternary adduct, Proteome•Zn-ZI. Next, we repeated the experiment with a model protein,
bovine serum albumin (BSA). BSA was chosen as the model protein for this experiment,
because it has been reported to have a zinc binding sites that are variably occupied with Zn2+
[100]. Therefore, its ability to bind Zn2+ reversibly seems to model proteomic binding of Zn2+. To
test its interaction with Zn2+ and ZI, 10 µM BSA in 20 mM Tris (pH 7.4) was first treated with 50
µM ZI (Figure 10 A). As expected, in the presence of BSA, ZI showed an absorption maximum at
490 nm, and no noticeable absorbance at 640 nm. However, as the mixture of 10 µM BSA and
50 µM ZI was titrated with Zn2+, a gradual increase of absorbance at 640 nm appeared, with the
disappearance of absorbance at 490 nm (Figure 10 A and B). This simultaneous increase of
absorbance at 640 nm and decrease at 490 nm suggested that BSA forms ternary complexes,
BSA•Zn-ZI, with ZI and Zn2+ bound to its non-specific zinc binding sites.
BSA + ZI + Zn2+  BSA•Zn-ZI (640 nm absorbance)

(22)

At the end of titration, the final reaction mixture was filtered using a Centricon 3K molecular
weight cut-off filter to separate the high molecular weight (retentate) and low molecular
weight (filtrate) fractions. Both fractions were analyzed for absorbance and zinc content. The
retentate displayed an absorption maximum at 640 nm and retained virtually all of the added
Zn2+ during titration, further confirming the formation of ternary complex, BSA•Zn-ZI (Figure 10
C and D).
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Figure 10. Reaction of BSA with ZI and Zn2+. (A) 10 µM BSA in 20 mM Tris (pH 7.4) was treated
with 50 µM ZI followed by titration with Zn2+. (B) Change of absorbance at 490 nm and 640 nm
with the increasing concentration of Zn2+. (C) Absorption spectrum of retentate and filtrate
following filtration of the final reaction of (A) using a Centricon 3K molecular weight cut-off
filter. (D) Zinc content of the retentate and filtrate fractions.
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The stoichiometry of BSA and Zn2+ was identified as well. 5 µM BSA in 20 mM Tris buffer (pH
7.4) was incubated with 13 different concentrations of Zn2+ between 2 – 80 µM. Subsequently,
each of the 13 reaction mixtures was filtered using Centricon 3K molecular weight cut-off filter
to separate the retentate and filtrate fractions. Zinc content in both retentate and filtrate
fractions was quantified. The amount of zinc in retentate and filtrate fractions was labelled as
‘bound zinc’ and ‘free zinc’, respectively. Total added zinc was plotted against the bound zinc to
identify the stoichiometry between BSA and zinc (Figure 11). From the plot, it appeared that 3540 nmol of zinc was required to saturate the zinc binding sites of 5 nmol of BSA, meaning that
each BSA molecule can potentially bind 7-8 zinc ions.
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Figure 11. Zinc binding of BSA. 5 µM BSA in 20 mM Tris buffer (pH 7.4) was incubated with
varying concentrations of zinc, and each mixture was then filtered using a Centricon 3K
molecular weight cut-off filter to separate the retentate from the filtrate fraction. Zinc content
was quantified in each fraction. Zinc content in the retentate fractions for each mixture (bound
zinc) was plotted against the total added zinc in each mixture.
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As a negative control, ternary complex formation experiment was conducted with trypsin to
test if ternary complex formation is independent of the existence of zinc binding site in a
protein. Trypsin was chosen because it has no potential zinc binding sites. First, interaction of ZI
with trypsin was examined by incubating 10 µM trypsin in 20 mM Tris buffer (pH 7.4) with 40
µM ZI. ZI did not display any interaction with trypsin, as evident from its absorption spectrum
centered at 490 nm (Figure 12 A). In addition, following filtration of the reaction mixture using
a Centricon 3K molecular weight cut-off filter, most of the absorbance was confined to the
filtrate (Figure 12 A), further indicating the lack of interaction between trypsin and ZI.
When the reaction mixture of 10 µM trypsin and 40 µM ZI was titrated with Zn2+, an increase of
absorbance at 620 nm was observed (Figure 12 B), suggesting the formation of Zn-ZI binary
complex. Moreover, change of absorbance at 620 nm with increasing concentration of Zn 2+ was
in alignment with that of control titration, i.e. titration of 40 µM ZI with Zn2+ in the absence of
trypsin (Figure 12 C). And the presence or an isosbestic point at – nm demonstrated that the
simple conversion of ZI to Zn-ZI had occurred in the titration. These results confirmed that
proteins need to have potential zinc binding sites for non-specific zinc binding.
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Figure 12. Titration of ZI with Zn2+ in the presence of trypsin. (A) Absorption spectra of the
reaction mixture of 10 µM trypsin and 40 µM ZI, and the retentate and filtrate following
filtration of the reaction mixture using a Centricon 3K molecular weight cut-off filter. (B)
Titration of 40 µM ZI with Zn2+ in the presence of 10 µM trypsin. (C) Change of absorbance with
increasing concentration during titration of 40 µM ZI with Zn2+ in the presence or absence of
Proteome or 10 µM trypsin.
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3.1.5 Absorption spectrum of Zn-ZI in different solvents
We considered the possibility that the shift of absorption maximum to 640 nm following the
addition of Zn2+ to the mixture of proteome and ZI originated from the presence of Zn-ZI
complex in a distinctive proteomic microenvironment, not from Proteome•Zn-ZI ternary
complex formation. To test this possibility, Zn-ZI solution was prepared in different solvents of
varying polarity and their absorption spectrum was recorded (Figure 13). In none of the cases
did Zn-ZI display an absorption spectrum similar to that obtained in the presence of Proteome
or Albumin, suggesting that the shift of absorption maximum to 640 nm during titration of ZI
with Zn2+ in presence of proteome was due to proteome•Zn-ZI ternary complex formation.
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Figure 13. Zn-ZI solution in different solvents. 10 µM Zn-ZI was prepared in various solvents
and absorption spectra were recorded
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3.1.6. Effect of N-ethylmaleimide (NEM) on proteome’s non-specific zinc binding
To further characterize proteome’s non-specific zinc binding, we attempted to identify the
proteomic components involved in adventitious zinc binding. Because cysteine residues are
predominantly present in zinc binding sites of native Zn-proteins, we hypothesized that
Proteome’s adventitious zinc binding sites involve sulfhydryl groups as well. To test the
hypothesis, Proteome’s zinc buffering capacity was examined following pre-incubation with Nethylmaleimide (NEM), a thiol-binding reagent that blocks the sulfhydryl groups [101]. Isolated
Proteome was first pre-treated with 500 µM NEM for an hour and then titrated with Zn 2+ in the
presence of 40 µM ZI. A control experiment was done proteome without any pre-treatment
with NEM. As expected, the control titration displayed zinc buffering capacity by Proteome, as
evident from very small increase of absorbance at the beginning of titration (Figure 14).
However, in case of NEM-treated Proteome, the increase in absorbance was immediate and did
not include the initial lag phase of the control titration (Figure 14), indicating that NEM pretreatment significantly reduced proteome’s high affinity non-specific zinc binding capacity.
Apart from this impact, the rest of the two curves are similar. While about 50 µM Zn 2+ was
needed to reach mid-point of the control titration, only about 30 µM Zn2+ was needed in case of
NEM-treated proteome experiment. These results clearly suggested that Proteome uses
sulfhydryl groups for high affinity, non-specific zinc binding. Once NEM has reacted with the SH
groups, there are lower affinity sites that are available for reaction with Zn and ZI. These are
the ones that yield the 640 nm absorbance.
Proteome-SH + Zn2+  Proteome-S•Zn (high affinity)

(23)

Proteome-SH + NEM  Proteome-S-NEM

(24)
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Figure 14. Effect of NEM on proteome’s non-specific zinc binding. Proteome was pre-treated
with 500 µM NEM for an hour. NEM-treated proteome was then reacted with 40 µM ZI
followed by titration with Zn2+. A control experiment was done with Proteome without any pretreatment with NEM. The absorbance increase of both titration experiments with the increasing
concentration of Zn2+ was plotted.

48

3. 2 Proteome mediated reconstitution of Zn-carbonic anhydrase
A eukaryotic cell contains about 3000 zinc proteins, among which zinc can have either structural
or catalytical role [4, 14]. Recent studies have reported that zinc can act as a secondary
messenger as well and participate in cellular signaling [53-57]. However, the trafficking
pathways that lead to the formation of thousands of native Zn-proteins following the entry of
zinc into the cytosol are not well understood. A few studies have reported that metallothionein,
a widely expressed protein with variable Zn content, can act as an intermediate in cellular zinc
trafficking and signaling [15, 31, 37, 38, 45]. Metallothionein (MT) has the ability to bind seven
zinc with very strong affinity and can transfer these zinc ions to apo-proteins to generate
native, specific Zn-proteins [34, 36]. However, metallothionein-null, MT gene knock-out cells
were found to proliferate normally, suggesting that metallothionein is not absolutely necessary
for the formation of Zn-proteins, which are critically important for cell survival [52]. Therefore,
the mechanism of zinc’s trafficking pathway remains unanswered.
As we have seen in the zincon study (section 3.1 above), the cellular proteome possesses a
large number of adventitious zinc binding sites, that involve primarily sulfhydryl groups. The
binding constant of the high affinity sites was calculated to be on the order of 10 10 M, which is
within the range of the stability constants (109 – 1012 M) of native Zn-proteins [11, 12].
Therefore, we have hypothesized that these proteomic, non-specific zinc binding sites
participate in trafficking zinc to the target proteins to generate native Zn-proteins. According to
our hypothesis, following the entry into cytosol, zinc trafficking via proteomic binding occurs in
two steps: (i) zinc binds to proteome at various non-specific sites primarily through sulfhydryl
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groups, and (ii) zinc is then transferred from these proteomic non-specific sites to apo-proteins
to make native, specific Zn-proteins via ligand substitution.
Zn2+out  Zn2+in

(transport into cells)

(25)

Zn2+in + Proteome-SH  Proteome-S•Zn + H+ (step I)

(26)

Proteome-S•Zn + apo-proteins + H+  Proteome-SH + Zn-proteins (step II)

(27)

This part of the thesis describes the experiments and their results to investigate the abovementioned zinc trafficking hypothesis.
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Step 1 of zinc trafficking hypothesis: Non-specific zinc binding by Proteome
3.2.1 Cellular distribution of extra Zn2+ after entry into cytosol
In order to probe the first step of our hypothesis that following the entry into cytosol, zinc first
binds at various non-specific zinc binding sites, LLC-PK1 cells were treated with 50 µM Zn2+ for
48 hours. Subsequently, cells were washed thoroughly to remove the extracellular residual zinc,
and the cellular supernatant was collected after sonication followed by centrifugation. The
cytosol was then fractionated using size exclusion chromatography with Sephadex G-75. A
control experiment was done with LLC-PK1 cells untreated with excess Zn2+, in which almost all
the cellular zinc (61 µM) was found to be associated with high molecular proteome fractions
and an insignificant pool of metallothionein zinc (2 µM) was observed (Figure 5). The result of
untreated LLC-PK1 cells was expected, because almost all the endogenous zinc in eukaryotic
cells is bound to various proteins, and LLC-PK1 cells express very little metallothionein under
basal conditions.
Next, cells were exposed to 50 µM Zn2+ for 24 h and then examined for the distribution of zinc.
The treatment of cell with excess zinc did not affect the cell viability (Figure 15 A). According to
the Sephadex G-75 chromatogram, the total zinc content was measured be to 2 nmol/107 cells
more than that of the control fractions, meaning that 2 nmol/107 cells of the added 200
nmol/107 cells could get into the cells (Figure 15 B and C). Moreover, high molecular weight
proteome fractions from the treated cells had 0.5 nmol/107 cells more Zn2+ than those from
control cells, indicating that 0.5 nmol/107 cells of the extra 2 nmol/107 cells Zn2+ (26%) ended up
being bound to proteome. Since the native zinc binding sites are already by 61 µM Zn2+, this
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extra 10 µM Zn2+ is assumed to be bound at non-specific sites of proteome. In addition, the
treatment of LLC-PK1 cells with zinc induced the synthesis of a significant amount of
metallothionein. About 1.45 nmol/107 cells more zinc was associated with metallothionein
fractions collected from treated cells (1.5 nmol/107 cells) than from control cells, meaning that
1.45 nmol/107 cells of the extra 2 nmol/107 cells Zn2+ (73%) was captured by the induced
metallothionein.
This is a very interesting finding, because this model reaction seems to support the first step of
our zinc trafficking hypothesis that zinc can bind at adventitious sites of proteome as well as to
metallothionein after making its way into the cytosol or cell supernatant. Although this type of
experiment has been done innumerable times, showing that Zn transported into cells induces
and then binds to MT, this is perhaps the first documenting that Zn associates both with MT
and the proteome. Nevertheless, what was not resolved is the form of the extra Zn in the
proteomic fractions. It could be Proteome•Zn (reaction 6) or it might be an adduct, ProteomeS-Zn7-MT, that provides additional zinc to the proteome via the association of Zn7-MT with
proteomic sulfhydryl groups (reaction 7).
Proteome-SH + Zn7-MT  Proteome-S•Znn + Zn(7-n)-MT

(28)

Proteome-SH + Zn7-MT  Proteome-S-Zn7-MT

(29)
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Figure 15. Distribution of added zinc between cellular proteome and metallothionein. (A)
Cells were released from one confluent plate of control and zinc treated cells by trypsin
treatment and stained with trypan blue to measure the cell viability. (B) 2x108 LLC-PK1 cells
were incubated in culture media supplemented with or without (control) 50 µM ZnCl2 for 48
hours. Following incubation, cells were harvested, washed, sonicated and centrifuged to collect
the supernatant, which was then fractionated using a Sephadex G-75 column. Zinc content in
each of the fractions was quantified using flame AAS. (C) Comparison of total proteomic and
metallothionein zinc in control and zinc treated cells. Error bar indicated standard deviation.
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3.2.2 Reaction of TSQ and proteome isolated from LLC-PK1 cells treated with exogenous Zn2+
According to Figure 15, we have found that 0.5 nmol/107 cells of 2 nmol/107 cells Zn2+ which
entered into cells was associated with high molecular weight proteome fractions. We have
shown that this extra zinc was bound to proteome at various adventitious zinc binding sites. To
test whether the additional Zn in the Proteome stems from Proteome-S•Zn or Proteome-S-Zn7MT, proteome collected from zinc treated cells was reacted with TSQ, a fluorescent sensor that
specifically binds to Zn-proteins as well as Zn2+. TSQ reacts with 15-20% of the native Znproteins to form TSQ-Zn-protein ternary complex, evidenced by the slow increase of
fluorescence with an emission maximum of 470 nm [76]. It does not react with Zn7-MT. With
non-specifically bound proteomic zinc, Proteome-S•Zn, TSQ reacts with a rapid enhancement of
fluorescence at 470 nm. Figure 16 shows the different reaction rate of native Zn-Proteins and
Proteome-S•Zn with TSQ. In contrast, Zn-MT is unreactive with TSQ. Therefore, the different
rate of TSQ fluorescence increase at 470 nm can differentiate between specifically (Zn-proteins)
and non-specifically bound proteomic zinc (Proteome-S•Zn) as well as Proteome-S-Zn7-MT (no
fluorescent contribution).

Zn-protein + TSQ  TSQ-Zn-protein (ternary complex, 470 nm, slow)

(30)

Proteome-S•Zn + TSQ  Proteome-S•Zn-TSQ (ternary complex, 470 nm, fast)

(31)

Proteome-S-Zn7-MT + TSQ  no reaction

(32)
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The reaction of control proteome (12.2 µM native Zn2+) collected from untreated LLC-PK1 cells
and 20 µM TSQ resulted in the slow increase of fluorescence centered at 470 nm, as expected,
indicative of the formation of TSQ-Zn-protein ternary complex with native Zn-proteins (Figure
17 A and C). On the other hand, proteome collected from cells treated with extra zinc (50 µM)
LLC-PK1 displayed a rapid two-fold increase of fluorescence at 470 nm, when reacted with 20
µM TSQ (Figure 17 B and C). This abrupt enhancement of TSQ fluorescence suggested that
extra zinc was non-specifically bound to proteome and TSQ formed ternary complexes,
proteome-S•Zn-TSQ, with them, which accounted for the fluorescence increase. This
experiment further supported the hypothesis that after entering into the cytosol, a significant
fraction of zinc binds proteomic adventitious sites, along with and perhaps in competition with
metallothionein.
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Figure 16. Reaction of zinc proteins with TSQ. (A) Isolated proteome containing 5.8 µM native
zinc was reacted with 20 µM TSQ, followed by the addition of 3 µM excess zinc. (B) Comparison
TSQ fluorescence before and after addition of 3 µM excess zinc.
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Figure 17. Reaction of proteome isolated from extra zinc treated cells with TSQ. (A and B)
2x108 LLC-PK1 cells were incubated in culture media supplemented with or without (control) 50
µM excess ZnCl2 for 48 hours. Following incubation, cells were harvested, washed, sonicated
and centrifuged to collect the supernatant, which was then fractionated using a Sephadex G-75
column. Proteome fractions were pooled together and reacted with 20 µM TSQ for 20 min.
Fluorescence spectra were recorded from 400 nm to 600 nm following excitation at 370 nm. (C)
Change of fluorescence at 470 nm with time from the reaction of proteome with TSQ.
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Step 2 of zinc trafficking hypothesis: Zinc transfer from non-specific binding sites
of Proteome to apo-Proteins
3.2.3. Reconstitution of a model apo-carbonic anhydrase with Proteome•Zn
The finding that Proteome-SH and Zn-MT establish an equilibrium distribution of Zn2+
reinforced the hypothesis that Zn2+ bound to Proteome plays a central role in the intracellular
trafficking of Zn2+ that leads to the constitution of native Zn-proteins from precursor apoproteins. To examine this hypothesis, we chose Zn-carbonic anhydrase as a model Zn-protein
and studied the reaction of apo-carbonic anhydrase with Proteome•Zn.
Proteome-S•Zn + apo-CA  Proteome-SH + Zn-CA

(33)

Carbonic anhydrase was chosen for the following reasons.
•

Known structure

•

Known Zn stability constant

•

Readily available

It does have the drawback that the apo-protein fully refolds into the native Zn-protein structure
even in the absence of Zn2+ [102]. Its preformed, relatively rigid structure prevents zinc ligand
flexibility as apo-CA reacts with Zn2+ bound to proteomic sites. Such lack of flexibility may act as
a steric barrier to accomplishing the ligand substitution reaction.
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Figure 18. Structure of Carbonic Anhydrase [102]
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3.2.4 Preparation of apo-carbonic anhydrase (apo-CA) from Zn-carbonic anhydrase (Zn-CA)
Apo-carbonic anhydrase (apo-CA) was prepared from Zn-carbonic anhydrase (Zn-CA) following
the protocol as described in methods [90, 91]. The extent of formation of apo-CA by the
reaction of the preparation with dansyl amide (DA), which is used as a fluorescent sensor for
Zn-CA [93].
Zn-CA + DA  DA-Zn-CA

(34)

When excited at 320 nm, DA, itself, displays a minor fluorescence emission with an emission
maximum at 540 nm. When reacted with free zinc, the emission maximum remains unaltered.
However, in the presence of Zn-CA, it forms a ternary complex, DA-Zn-CA, that causes a blue
shift of its emission maximum to 460 nm. As the prepared apo-carbonic anhydrase was reacted
with DA, emission maximum was found to be 540 nm and no significant fluorescence observed
at 460 nm, indicating that the protocol successfully removed zinc from Zn-CA and apo-CA was
formed (Figure 19). Direct measurement of Zn by atomic absorption spectrophotometry
demonstrated that apo-CA preparations typically contained 6% of their original content of zinc.
By contrast, the reaction of Zn-CA and DA produced fluorescence centered at 460 nm,
indicating the formation of ternary complex, DA-Zn-CA (Figure 19). A titration of Zn-CA with DA
showed that about 1.6 µM DA was needed to completely react with 1 µM Zn-CA (Figure 20).
The reaction of 1 µM Zn-CA and 1.6 µM DA was fast and displayed about 1900±100
fluorescence units under the conditions of the measurements (reaction 12 and Figure 19).
Zn2+ + DA  No reaction (emission maximum 540 nm)

(35)

apo-CA + DA  No reaction (emission maximum 540 nm)

(36)
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Figure 19. Emission spectra of dansyl amide (DA) in the presence of free zinc, apo-CA or ZnCA. 1.6 µM dansyl amide (DA) in 20 mM Tris (pH 7.4) was treated with 1 µM Zn 2+ or apo-CA or
Zn-CA. The resulting solutions were then excited at 320 nm and fluorescence spectra were
recorded from 400 nm to 600 nm.
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Figure 20. Titration of Zn-CA with dansyl amide. (A) 1 µM Zn-carbonic anhydrase (Zn-CA) in 20
mM Tris (pH 7.4) was titrated with the increasing concentrations of dansyl amide (DA).
Following each addition, the reaction mixture was excited at 320 nm and fluorescence was
recorded from 400 to 600 nm. (B) Maximum fluorescence of each spectrum from (A) was
plotted against the concentration of dansyl amide.
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3.2.5 Reaction of apo-carbonic anhydrase (apo-CA) with Zn2+ in the presence of dansyl amide
(DA)
The prepared apo-carbonic anhydrase was tested for reconstitution of Zn-CA by reacting with
Zn2+ and monitoring product formation with dansyl amide (DA) (Figure 21). When 1 µM Zn2+
was added to 1.6 µM DA, no change of fluorescence was observed, as expected. However, upon
addition of 1 µM apo-CA, a dramatic increase of fluorescence occurred, and the emission
maximum immediately shifted from 540 nm to 460 nm, indicative of the formation of Zn-CA
(Figure 21). The final measurement of fluorescence units indicated that almost 100% Zn-CA was
reconstituted from this reaction. Direct measurement of the zinc content of the product
confirmed the reconstitution of Zn-CA.
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Figure 21. Reaction of apo-CA and Zn2+ to reconstitute Zn-CA in the presence of dansyl
amide. (A) 1.6 µM dansyl amide was treated with 1 µM ZnCl2 followed by the addition of 1 µM
apo-CA. Fluorescence spectra of the reaction mixture from 400 – 600 nm (excitation 320 nm)
was recorded every 5 min for 20 min. (B) Fluorescence at 460 nm of the spectra from (A) was
plotted against time.
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3.2.6 Reconstitution of Zn-carbonic anhydrase (Zn-CA) mediated by proteome
To test whether proteome can mediate zinc transfer to apo-carbonic anhydrase via its nonspecific zinc binding sites and thus reconstitute Zn-carbonic anhydrase, first, isolated proteome
containing 5 µM native Zn2+ was reacted with 1.6 µM dansyl amide (Figure 22). The emission
maximum was found to be 540 nm, suggesting that either (i) isolated proteome contained very
low concentration of Zn-CA in its native Zn-protein pool, or (ii) even if proteome had noticeable
amount of Zn-CA, the reaction is very slow in the proteomic environment. This experiment also
indicated that dansyl amide does not display significant reactivity with other native Zn-proteins.
Next, 2 µM exogenous Zn2+ was added in the form of ZnCl2 to the mixture of proteome and
dansyl amide. Since proteome can bind extra Zn2+ via non-specific zinc binding sites involving
primarily sulfhydryl groups, 2 µM proteome-S•Zn was assumed to be formed following the
addition of 2 µM Zn2+. The unchanged fluorescence at 525 nm indicated that DA did not react
with free Zn2+ or non-specifically bound proteomic zinc, Proteome•Zn (Figure 22).
Subsequently, 1 µM apo-CA was added to the reaction mixture of Proteome•Zn and dansyl
amide. Following the addition, dansyl amide fluorescence started to increase slowly, the
emission maximum the fluorescence blue-shifted from 525 nm to 460 nm, clearly indicating
reconstitution of Zn-CA resulting from the transfer of zinc to apo-CA from proteome’s nonspecific sites. The progress of the experiment can be summarized by the following reactions.
Proteome + Zn2+  Proteome•Zn

(37)

Proteome•Zn + apo-CA  Proteome + Zn-CA

(38)

Zn-CA + DA  DA-Zn-CA (460 nm)

(39)
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Figure 22. Proteome-mediated reconstitution of Zn-CA from apo-CA. (A) Isolated proteome
containing 5.2 µM native Zn2+ was treated with 1.6 µM DA followed by the addition of 2 µM
exogenous Zn2+ and 1 µM apo-CA. Fluorescence spectra of the reaction mixture (excitation 320
nm, emission 400-600 nm) was monitored for 3 hours. (B) Change of fluorescence at 460 nm
with time.
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As shown in Figure 22, the reconstitution of Zn-CA in presence of proteome is very slow. While
in the absence of proteome, almost 100% reconstitution occurred rapidly, it took several hours
for only about 50% Zn-CA reconstitution to occur in presence of proteome. Evidently, binding
zinc to the Proteome markedly slowed the kinetics of the reaction. In addition, it makes the
energetics of the reaction much less favorable. Also considering that Zn 2+ bound to
Proteome•Zn probably has a full complement of ligands in its coordination sphere (≥4), the
complete ligand substitution reaction is complex and may be slowed simply because of the
difficulty in exchanging, sequentially, multiple ligands between two large, bulky ligand sets,
which must involve the formation of an intermediate (reaction 40).
Proteome•Zn + apo-CA  Proteome•Zn-CA  Proteome + Zn-CA

(40)

To further explore role of energetics in the proteome-mediated reconstitution of Zn-CA, 1 µM
apo-CA was reacted with 1 µM exogenous Zn2+ in the presence of various concentrations of
proteome and their reaction monitored with dansyl amide. Proteome containing 9 µM native
Zn2+ was serially diluted and used in this reaction. Figure 23 shows that with increasing
concentration of Proteome, both the extent and the rate of Zn-CA reconstitution declined. The
inverse relationship of Proteome concentration and the fraction of Zn-CA reconstitution can be
explained by the hypothesis that at higher concentration, Proteome possesses larger number of
non-specific zinc binding sites, possibly sulfhydryl groups, and thus provides stronger
competition for exogenous Zn2+ with apo-CA, leading to the smaller regeneration of Zn-CA.
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Figure 23. Effect of proteome concentration on proteome-mediated Zn-CA reconstitution.
Isolated proteome containing 9 µM native Zn2+ was serial diluted in 20 mM Tris buffer (pH 7.2).
Proteome solution containing 9 µM, 4.5 µM, 2.25 µM or 1.1 µM native Zn2+ was treated with
1.6 µM DA followed by the addition of 1 µM exogenous Zn2+ and 1 µM apo-CA. Fluorescence
spectra of the reaction mixture (excitation 320 nm, emission 400-600 nm) was monitored for 2
hours. Fluorescence at 460 nm of the spectra was plotted against time.
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These results are in good agreement with the KProteome•Zn determined in the reaction of FluoZin3 with Proteome•Zn (Karim and Petering, unpublished data). That fact supports the view that
the reaction of apo-CA with Proteome•Zn can be treated as a straight-forward ligand
substitution process between the protein and Zn2+ bound in equilibrium fashion to a number of
proteomic sites.
The decline in rate of reaction as one of the reactant concentrations was reduced suggests that
the kinetics of the ligand substitution process has second order character, first order in each
reactant. Section 3.2.10 examines the kinetics of reaction 10.
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3.2.7. Effect of N-ethylmaleimide (NEM) on proteome mediated reconstitution of Zn-CA
According to previous work as well as current studies of the reaction of Zincon with
Proteome•Zn, the high affinity zinc binding sites in the Proteome include sulfhydryl groups.
Experiments were conducted to confirm that reaction 10 involves Zn2+ bound to proteomic
thiolate groups. In particular, the effect of N-ethylmaleimide (NEM), a thiol binding reagent, on
proteome mediated reconstitution of Zn-CA was examined.
Proteome-SH + NEM  Proteome-S-NEM

(41)

In doing so, isolated proteome containing 4 µM native Zn2+ was pre-incubated with different
concentrations of NEM for 30 min. Reaction mixture was then filtrated using a 3K molecular
weight cut-off filter to remove residual NEM. The retentate proteome was subsequently
reacted with 1 µM exogenous Zn2+ and 1 µM apo-CA. As displayed in Figure 24, the pretreatment of Proteome with increasing concentrations of NEM caused a large, progressive
increase in the rate of Zn-CA regeneration, confirming that proteomic sulfhydryl groups are
implicated in non-specific zinc binding and in competition with apo-CA for exogenous Zn2+. NEM
abolished proteomic sulfhydryl groups and high affinity, non-specific zinc binding sites, which
weakened but did not abolish the Proteome’s competition with apo-CA for Zn2+. In place of
Proteome-SH, Zn2+ became bound to sites containing ligands other than sulfhydryl groups, such
as imidazole and carboxylate groups. In this situation the energetics are more favorable for the
formation of Zn-CA and clearly the kinetics of reaction are faster.
Proteome-S•Zn + apo-CA  Proteome-S- + Zn-CA (slow)

(42)

Proteome-S- + NEM  Proteome-S-NEM

(43)

72

Proteome•Znweak sites + apo-CA  Zn-CA + Proteome (fast)

(44)

As the concentration of NEM was increased, favoring the titration of sulfhydryl groups, the
number of residual proteomic SH groups decreased though not in a linear fashion.
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Figure 24. Effect of N-ethylmaleimide (NEM) on proteome mediated reconstitution of Zn-CA.
(A-D) Isolated proteome containing 4 µM native Zn2+ was pre-incubated with (A) 62.5 µM, (B)
125 µM, (C) 250 µM or (D) 500 µM N-ethylmaleimide (NEM) for 1 hour. Subsequently, each of
the four reaction mixtures was filtered using 3K molecular weight cut-off filter in order to
remove unreacted and residual NEM. NEM-treated and filtered proteome was then treated
with 1.6 µM dansyl amide followed by the addition of 1 µM exogenous Zn 2+ and 1 µM apo-CA.
Fluorescence spectra of the reaction mixture (excitation 320 nm, emission 400 – 600 nm) was
recorded for 3 hours. As control, proteome without NEM treatment was reacted with 1.6 µM
dansyl amide, 1 µM exogenous Zn2+ and 1 µM apo-CA. (E) Fluorescence at 460 nm of the
reactions (A – D) was plotted against time.
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3.2.8. Reaction of Proteome-S•Zn with denatured apo-CAd
One likely difference in these in vitro experiments and native, cellular conditions is that the in
vitro experiment used pre-folded, native apo-CA for reconstitution (reaction 45), while under
native conditions zinc possibly binds to unfolded apo-CA to form native, folded Zn-CA (reaction
46). The latter case may thermodynamically favor the reaction and thus facilitate the
generation of Zn-CA. It might also enhance the kinetic rate of reaction by making available a
set of flexible ligands to react with Proteome-S•Zn instead of the highly constrained trio of
imidazole ligands present in native apo-CA.
Proteome-S•Zn + apo-CAnative  Proteome-SH + Zn-CA (slow)

(45)

Proteome-S•Zn + apo-CAunfolded  Proteome-SH + Zn-CA (fast)

(46)

Therefore, the proteome-assisted Zn-CA reconstitution experiment was repeated with
denatured (unfolded) apo-CA, instead of already folded, native apo-CA, to see if the extent and
rate of reconstitution becomes faster.
Apo-CA was denatured by guanidinium hydrochloride treatment. To verify this denaturation
protocol, 25 µM native Zn-CA was treated with 4M guanidium hydrochloride in the presence of
25 µM dansyl amide (Figure 25). The complete loss of DA fluorescence following addition of
guanidinium hydrochloride demonstrated that this protocol could successfully denature Zn-CA.
Moreover, 25-fold dilution of guanidinium hydrochloride abolished its denaturing capacity and
thus resulted in reconstitution of Zn-CA, evidenced from the gradual increase of dansyl amide
fluorescence at 460 nm (Figure 26 A). The final fluorescence intensity was comparable to that
of 1 µM Zn-CAnative (Figure 26 B) . The result was also consistent with the control experiment, in
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which 1 µM denatured apo-CA was reacted with 1 µM Zn2+ in the presence of 1.6 µM dansyl
amide. The lower fluorescence intensity in this experiment relative to the previous experiments
under identical condition resulted from the different settings of the fluorometer parameters
used in the two experiments.
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Figure 25. Denaturation of Zn-CA by guanidinium hydrochloride treatment. (A) 25 µM Zn-CA
was reacted with 25 µM dansyl amide followed by the addition of 4 mM guanidinium
hydrochloride for 10 min. Fluorescence spectra were recorded using excitation wavelength 320
nm and emission wavelength 400 – 600 nm. (B) Change of 460 nm fluorescence with time
following the addition of guanidinium hydrochloride.
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Figure 26. Renaturation of Zn-CA in the presence of diluted guanidinium hydrochloride. (A)
The final reaction mixture of 25 µM Zn-CA, 25 µM dansyl amide and 4 mM guanidinium
hydrochloride was diluted 25-fold with 25 mM Tris buffer (pH 7.4). Dansyl amide fluorescence
was recorded using excitation wavelength 320 nm and emission wavelength 400 – 600 nm. (B)
Reaction of 1 µM denatured apo-CA and 1 µM Zn2+ in the presence of 1.6 µM dansyl amide. (C)
Comparison of the kinetics of the reactions (A) and (B).
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Apo-CA was denatured using the same protocol and 1 µM denatured apo-CA was then reacted
with 1 µM Zn2+ in the absence (Figure 27) or presence of proteome (Figure 28). Interestingly,
the rate of proteome-assisted reconstitution of Zn-CA from denatured apo-CA was not
significantly different from that with native apo-CA (Figure 28). But the extent of reconstitution
of the denatured protein was only about half as much as that of native apo-CA.
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Figure 27. Reaction of denatured apo-CA and Zn2+ in the presence of dansyl amide. (A) 1 µM
denatured apo-CA was reacted with 1 µM Zn2+ in the presence of 1.6 µM dansyl amide.
Fluorescence spectra at excitation wavelength 320 nm and emission wavelength 400 – 600 nm
were recorded for 90 min. (B) Change of 460 nm fluorescence with time
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Figure 28. Comparison of proteome-mediated Zn-CA reconstitution from native and
denatured apo-CA. Isolated proteome was treated with 1.6 µM DA followed by the addition of
1 µM exogenous Zn2+ and (A) 1 µM denatured or (B) native apo-CA. Fluorescence spectra of
both reactions (excitation 320 nm, emission 400-600 nm) was recorded. (C) Comparison of rate
of Zn-CA reconstitution from native and denatured apo-CA.
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3.2.9 Reaction kinetics of proteome mediated reconstitution of Zn-CA
In the native environment, i.e., in cells, the rate of formation of Zn-proteins might be expected
to be relatively fast as considered in the Discussion (section 4). If so, then the apparent slow
rate of reconstitution of apo-CA observed in Figure 22 may suggest that the direct reaction of
apo-CA with Proteome-S•Zn is not kinetically competent to serve as the direct pathway for the
constitution of apo-Zn proteins in vivo.
In order to gain deeper insight into the reconstitution of Zn-CA mediated by the Proteome, the
kinetics of Zn-CA formation from the reaction of apo-CA and Proteome-S•Zn were investigated.
Potentially, the involvement of multiple reactants within Proteome-S•Zn make the kinetic study
of this reaction complicated. A pseudo-first order rate study was done by using a large excess
of apo-CA relative to Proteome-S•Zn. First, 1 µM proteome-S•Zn was generated by reacting
proteome containing - µM native Zn2+ with 1 µM exogenous Zn2+. Then, 10, 20 or 30 µM apo-CA
was added and the progress of reaction was monitored with 1.6 µM DA. As anticipated,
increased rate of Zn-CA regeneration was observed with increasing concentration of apo-CA
(Figure 29 A-D). Initially, we hypothesized that this reaction was second order, first order in
both reactants, apo-CA and Proteome-S•Zn.
Rate of Zn-CA reconstitution = k [Proteome-S•Zn] [apo-CA]

(47)

where k is the second order rate constant.
Since [apo-CA] was used in large excess relative to [Proteome-S•Zn], [apo-CA] was assumed to
be constant for the pseudo-first order reaction. Therefore, the above rate equation can be
modified as below.
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Rate of Zn-CA reconstitution = k’ [Proteome-S•Zn]

(48)

or d[Proteome-S•Zn]/dt = -k ‘[Proteome-S•Zn]

(49)

where k’ = observed rate constant = k [apo-CA]

(50)

The integrated form of equation (48) can be re-written as,
ln[proteome-S•Zn]t = ln[Proteome-S•Zn]0 – k’t
where [Proteome-S•Zn]t = concentration of Proteome-S•Zn at time t

(51)
(52)

Next, for each of these three reactions, the concentration of Proteome-S•Zn, [Proteome-S•Zn]t,
was calculated at different time points for the first 20 minutes using the following equation.
[Proteome-S•Zn]t = [Proteome-S•Zn]0 - [{(Fmax – Ft) / (Fmax - Fmin)}*[proteome-S•Zn]0]

(53)

Fmax = maximum fluorescence units upon completion of the reaction; Ft = fluorescence units at
time t; and Fmin = background fluorescence before the addition of apo-CA. [proteome-S•Zn]0 =
initial concentration of Proteome-S•Zn = 1 µM
A plot of ln[proteome-S•Zn]t versus t was made for each of three reactions (Figure 29 E). The
slopes of the resulting straight lines were calculated to find the values of observed rate
constants, k’ for each reaction. Finally, the observed rate constants, k’, were plotted against
the concentration of apo-CA, [apo-CA], producing another straight line (Figure 29 F). According
to equation (50), the slope of this straight line is the actual rate constant, k. The value of k was
measured to be 23 M-1s-1.
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Figure 29. Reaction kinetics of proteome-mediated reconstitution of Zn-CA. (A – C) Isolated
proteome was treated with 1.6 µM dansyl amide followed by the introduction of 1 µM
exogenous Zn2+ and (A) 10 µM, (B) 20 µM or (C) 30 µM apo-CA. Fluorescence spectra of the
reactions (excitation 320 nm, emission 400 – 600 nm) were recorded. (D) Fluorescence at 460
nm of each of the three reactions (A – C) was plotted against time. (E) Concentration of
proteome-S•Zn (lnA) was calculated for each of three reactions for first 20 minutes and plotted
against time. (F) The slope of the straight lines (kobs) from (E) was plotted against the
concentration of apo-CA.
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3.3 Metallothionein-mediated reconstitution of Zn-CA
We examined two possible reasons to explain the slow rate of Zn-CA reconstitution in presence
of proteome. Since formation of native Zn-proteins in the cellular environment is supposed to
occur faster, we hypothesized that cellular components other than proteome protein, e.g.,
metallothionein, glutathione, etc., that may be more kinetically reactive, are involved, as well,
in proteome-mediated zinc trafficking to generate native Zn-proteins.
Metallothionein is a small protein with very strong binding affinity for Zn2+ [29, 31]. It has 60
amino acid residues, of which 20 are cysteine residues [34, 35]. Each metallothionein molecule
can bind up to seven zinc ions with stability constant of 1011-12 [37, 38]. Due to this high affinity,
some studies have claimed that metallothionein acts as a thermodynamic sink for zinc following
cellular uptake. Various studies have reported that metallothionein plays important role in
cellular zinc trafficking and thus in the formation of native, specific Zn-proteins [15, 31, 37, 38,
45]. Therefore, it is expected that metallothionein will possibly have an impact on proteomeassisted zinc trafficking. It can either directly transfer its zinc to the apo-proteins producing Znproteins (reaction 54), or can establish an equilibrium with proteome, eventually transferring zinc
to apo-proteins (reactions 55 and 56).
Zn7-MT + apo-protein  Zn(7-n)-MT + Zn-protein
Zn7-MT + Proteome-SH  Zn(7-n)-MT + Proteome-S•Zn
Proteome-S•Zn + apo-protein  Proteome-SH + Zn-protein
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(54)
(55)
(56)

In this chapter, we have investigated metallothionein-mediated reconstitution of Zn-CA either
in the absence or presence of proteome. The interaction of metallothionein with proteome was
probed, too. For this purpose, Zn7-MT purchased from Creative Biomart was employed.
However, before using it in reactions, its zinc and sulfhydryl content and zinc binding affinity
were characterized.
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3.3.1 Characterization of Zn7-MT purchased from Creative Biomart
The seven zinc ions of metallothionein should be tightly bound to it with equal or similar affinity,
first it was confirmed if the purchased metallothionein has any free or loosely bound zinc in it. In
doing so, the purchased metallothionein containing 5 µM was reacted with 5 µM FluoZin-3, a
fluorescent zinc sensor with relatively high stability constant (Kd 15 nM). FluoZin-3 forms a 1:1
complex, Zn-FluoZin3, with zinc and shows a significant enhancement of fluorescence at 518 nm,
when excited at 492 nm. However, it does not display any noticeable reactivity with the tightly
bound zinc of metallothionein.
Zn2+ + FluoZin3  Zn-FluoZin3 (excitation 492 nm, emission 518 nm)

(57)

Zn7-MT + FluoZin-3  No reaction

(58)

5 µM FluoZin-3 solution in 20 mM Tris buffer (pH 7.4) showed a background fluorescence of
about 2000 units at 518 nm. When reacted with 1.54 µM free Zn2+, a rapid three-fold
enhancement of fluorescent at 518 nm was observed (Figure 30 B). However, the reaction of 5
µM FluoZin-3 with purchased metallothionein containing 5 µM Zn 2+ generated only about 2000
fluorescence units (Figure 30 C), equal that of background fluorescence in Tris buffer, at 518 nm,
suggesting that the purchased metallothionein contained little or no free zinc. The lack of any
slow step in the gain of fluorescence also was consistent with the lack of reactivity of MT-bound
Zn2+ with FluoZin-3. The presence of free zinc in the purchased metallothionein was checked by
another way. Metallothionein solution containing 5 µM Zn2+ was filtered using 3K molecular
weight cut-off filter and the resulting filtrate was then reacted with 5 µM FluoZin-3. The reaction
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produced only background fluorescence at 518 nm (Figure 30 D), further confirming that the
purchased metallothionein did not contain any free zinc.
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Figure 30. Reaction of FluoZin-3 with ZnCl2 or Zn7-MT. (A - C) 5 µM FluoZin-3 in (A) 20 mM Tris
buffer (pH 7.4) was treated with (B) 1.54 µM ZnCl2 or (C) Zn7-MT containing 5 µM Zn2+.
Fluorescence spectra of the reaction mixtures (excitation 492 nm, emission 500 – 600 nm) was
recorded with time. (D) Zn7-MT (5 µM Zn2+) in 20 mM Tris buffer (pH 7.4) was filtered using a 3K
molecular weight cut-off filter, and the resulting filtrate was treated with 5 µM FluoZin-3 followed
by the recording of fluorescence spectra at excitation 492 nm and emission 400 – 600 nm. (E)
Comparison of spectra of the reactions. (F) Comparison of fluorescence change over time of the
reactions of FluoZin-3 with ZnCl2 and Zn7-MT.
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Next, zinc content of the purchased metallothionein was examined. A fully saturated Zn7metallothionein should have seven zinc ions and the ratio of zinc to sulfhydryl groups should be
1:2.86. Zinc content in metallothionein was quantified using inductively coupled plasma mass
spectrometry and the sulfhydryl groups using DTNB (5,5’-dithiobis-(-nitrobenzoic acid) assay.
Free sulfhydryl groups react with DTNB stoichiometrically, resulting in the cleavage of its disulfide
bond and production of 5-thio-2-nitrobenzoic acid (TNB), which shows absorbance at 412 nm
with an extinction coefficient of 13,600 M-1cm-1 [89]ahn. First, 3.7 µM purchased metallothionein
was reacted with 1 mM DTNB to find out the time needed for the reaction to reach completion.
The change of absorbance at 412 nm with time as in figure 31 showed that in about 30 min, the
reaction was complete. Therefore, to quantify the sulfhydryl groups of the purchased
metallothionein, it was 10-fold serial diluted (75.7 µM, 7.57 µM and 0.75 µM) and incubated with
1 mM DTNB for 30 min followed by reading absorbance at 412 nm. Using the extinction
coefficient of 13,600 M-1cm-1, the concentration of sulfhydryl groups was calculated. The ratio of
zinc to sulfhydryl groups in the purchased metallothionein was measured to be 1:3.1, suggesting
that metallothionein was fully saturated with seven zinc, Zn7-metallothionein.
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Figure 31. Quantification of sulfhydryl groups in metallothionein by DTNB assay. 3.7 µM
metallothionein in 20 mM Tris buffer (pH 7.4) was reacted with 1 mM DTNB. The reaction
progress was monitored by recording the absorbance at 412 nm.
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3.3.2 Metallothionein-mediated reconstitution of Zn-CA
In order to investigate if metallothionein can help reconstitute zinc carbonic anhydrase from apocarbonic anhydrase, Zn7-metallothionein (Zn7-MT) containing 1 µM Zn2+ was reacted with 1 µM
apo-CA in the presence of 1.6 µM dansyl amide (DA). The gradual increase of fluorescence at 460
nm indicated the formation of DA-Zn-CA ternary complex (Figure 32 A), meaning that zinc was
transferred from Zn7-MT to apo-CA and thus Zn-CA was reconstituted. However, like proteome,
metallothionein-mediated reconstitution of Zn-CA occurs at a slow rate.
Zn7-MT + apo-CA  Zn6-MT + Zn-CA

(59)

Interestingly, the introduction of proteome containing 4 µM native Zn 2+ further slowed down
the rate of reconstitution of Zn-CA (Figure 32 B and C). When the reaction was carried out with
denatured, unfolded apo-CA, similar slow reconstitution of Zn-CA was observed (Figure 32 D).
The sluggish rate of the observed reactions might be due to the possibility that there existed an
equilibrium between proteome and Zn7-MT, resulting in the slow transfer of zinc to apo-CA.
Zn7-MT + Proteome-SH  Zn6-MT + Proteome-S•Zn
Proteome-S•Zn + apo-CA  Proteome-SH + Zn-CA

(60)
(61)

Alternatively, proteome may form ternary complex with Zn7-MT as an intermediate during
reaction X and, thus, slow down the transfer of zinc from metallothionein to apo-CA.
Proteome-SH + Zn7-MT  Proteome-S•Zn7-MT
Proteome-S•Zn7-MT + apo-CA  Proteome-SH + Zn6-MT +Zn-CA

100

(62)
(63)
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Figure 32. Metallothionein-mediated reconstitution of Zn-CA. (A) Zn7-MT containing 1 µM Zn2+
in 20 mM Tris buffer (pH 7.4) was reacted with 1 µM native apo-CA in the absence (control) or
presence of proteome containing 4 µM native Zn2+. The reconstitution of Zn-CA was monitored
with 1.6 µM dansyl amide. Fluorescence spectra of the reactions were recorded at excitation
320 nm and emission 400 – 600 nm. (B) Zn7-MT containing 7 µM Zn2+ in 20 mM Tris buffer (pH
7.4) was reacted with 1 µM denatured apo-CA in presence of proteome containing 12.5 µM
native Zn2+ and 1.6 µM dansyl amide. (C) Comparison of the rate of metallothionein-mediated
Zn-CA reconstitution in the absence or presence of proteome. (D) Metallothionein-mediated
reconstitution of Zn-CA from denatured apo-CA in the presence of proteome.
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We tested the zinc transfer equilibrium between proteome and Zn 7-metallothionein may
account for the depression of the rate of reaction of Zn 7-MT with apo-CA illustrated in Figure
33. For this purpose, Proteome containing 7.5 µM native Zn2+ was treated with 500 µM N-ethyl
maleimide (NEM) for 1 hour to block the proteomic sulfhydryl groups and thus, its high affinity,
zinc binding sites. Next, the resulting reaction mixture was filtered using a 3K molecular weight
cut-off filter in order to remove the residual NEM. The NEM-treated and filtered proteome was
then reacted with Zn7-MT and apo-CA. Interestingly, a significant increase in the rate of Zn-CA
reconstitution was observed (Figure 33), confirming that the proteomic thiolate sites inhibit the
rate of ligand substitution between Zn7-MT and apo-CA. According to our hypothesis, following
the treatment with NEM, proteomic sulfhydryl groups were abolished and therefore the
equilibrium between Proteome and Zn7-MT was lost, resulting in direct transfer of zinc from
Zn7-MT to apo-CA and the rate enhancement of Zn-CA reconstitution.
Proteome-SH + NEM  Proteome-S-NEM

(64)

This experiment did not distinguish whether the role of Proteome-SH was to fully acquire Zn2+
from Zn7-MT, altering the pathway of trafficking of Zn2+ to apo-CA or whether it had formed a
ternary adduct with Zn7-MT, Proteome-S-Zn7-MT that reduced the rate of direct transfer of Zn2+
from Zn7-MT to apo-CA.
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Figure 33. Reaction of Zn7-MT with apo-CA in the presence of NEM-treated Proteome.
Proteome containing 7.5 µM Zn2+ was treated with 500 µM NEM for 1 hour, and subsequently,
filtered using a 3K molecular weight cut-off filter to remove the unreacted NEM. Filtered
proteome was then reacted with Zn7-MT containing 1 µM Zn2+ and 1 µM apo-CA. The reaction
was monitored in the presence of 1.6 µM dansyl amide. As the control, the reaction was done
with Proteome without NEM treatment. Fluorescence spectra of both reactions were recorded
at excitation 320 nm and emission 400 – 600 nm.
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3.3.3 In vitro distribution of Zn2+ between proteome and metallothionein
To explore if there existed any equilibrium between proteome and Zn-metallothionein, isolated
proteome containing 40 µM native Zn2+ was incubated for an hour with Zn7-MT having 50 µM
Zn2+. Subsequently, the reaction mixture was fractionated using size exclusion chromatography
and each fraction was quantified for zinc content. As the control, untreated Proteome having
40 µM native Zn2+ or Zn7-metallothionein containing 50 µM Zn2+ was fractionated with
Sephadex G-75 and the zinc content in each fraction was measured. In the case of control
Proteome, almost all zinc was found to be associated with high molecular weight Proteomic
fractions (fraction 10-20). Likewise, following fractionation of control metallothionein, all of its
Zn2+ was recovered from the corresponding metallothionein fractions (fraction 25-35). By
contrast, a significant redistribution of zinc occurred between Proteome and metallothionein
following their mixing (Figure 34 and Table 1). The total zinc content in Proteome fractions
(47.1±3.9 µM) was found about 10 µM more than that in control proteome fractions (40 µM).
Consistently, metallothionein fractions had about 10 µM less Zn2+ (reduced to 39.3±5.5 µM
from 50 µM) after incubation with Proteome. This rearrangement of proteomic and
metallothionein zinc clearly indicated that there existed an equilibrium between proteome and
Zn7-MT, which can be explained by either ligand substitution (reaction 60 above) or ternary
complex formation (reaction 62 above).
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Figure 34. Isolated Proteome (40 uM Zn2+) from LLC-PK1 cells was reacted with Zn7-MT (50 uM
Zn2+) for 30 min. The reaction mixture was then loaded onto a Sephadex G-75 column and
eluted with 20 mM degassed Tris buffer (pH 7.4). As controls, Proteome or metallothionein was
loaded and eluted with Tris buffer. The zinc content in each fraction was measured by flame
AAS.
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Table 1. Zinc redistribution between Proteome and metallothionein following the incubation of
proteome containing 40.4 µM native Zn2+ with Zn7-MT (50 µM Zn2+). The results are based on
three runs and show the average ± standard deviation.

Control : proteome
Control : MT
Proteome + MT

[Zn2+], µM
40.4

HMW [Zn2+], µM
38.3  0.9

50
40.4

50

47.1 3.9
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LMW [Zn2+], µM

49.5 0.2
39.3 5.5

3.4 Role of glutathione (GSH) in cellular zinc trafficking
We have already seen that proteomic sulfhydryl groups have a critical involvement in
proteome-mediated zinc trafficking (Section 3.2.8 and Figure 24), presumably, other cellular
components containing sulfhydryl groups have important roles in cellular zinc trafficking, as
well. Consequently, we have investigated if glutathione (GSH) plays any part in the landscape of
cellular zinc trafficking.
Glutathione is a small molecule and a tripeptide having one sulfhydryl group. In cells, it has a
key antioxidant function that involves its thiol group and, thus prevents cellular damage caused
by reactive oxygen species [103]. It also forms S-conjugates with reactive metabolites of
xenobiotics [104]. One of the notable features of glutathione is its presence in cells at relatively
high concentration, namely, 1-10 mM [85]. In addition, it has a moderate zinc binding affinity
(Kd ⁓ 10-4.2 M at pH 7) [105], that supports the hypothesis that glutathione plays an important
role in overall zinc trafficking. This chapter focuses on this hypothesis and particularly on (i) the
impact of glutathione on proteome- and/or metallothionein-mediated reconstitution of Zn-CA
from apo-CA and (II) the possibility that GSH is a central player in cellular zinc trafficking.
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3.4.1. Reconstitution of Zn-CA in the presence of glutathione
To examine if glutathione affects the rate of Zn-CA reconstitution, 1 µM apo-CA was reacted
with increasing concentration of Zn2+ in the presence of 1 mM glutathione (GSH). In the
absence of GSH, i.e., in control experiment, the rate of Zn-CA reconstitution from the reaction
of 1 µM apo-CA and 1 µM Zn2+ was rapid as expected (Figure 35). However, the introduction of
1 mM GSH noticeably slowed down Zn-CA reconstitution even when a larger concentration of
Zn2+ (2.5 µM) was used (Figure 35), implying that glutathione mediates zinc transfer to apo-CA
and thus slows down the formation of Zn-CA (reaction 65) because ligand substitution must
take place between apo-CA and zinc bound to GSH (reaction 66) instead of zinc associated with
water (reaction Y).
GSH + Zn2+  GS-Zn

(64)

GS-Zn + apo-CA  GSH + Zn-CA (slow)

(65)

With increasing concentration of Zn2+, the rate of Zn-CA formation was enhanced, as expected.
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Figure 35. Reconstitution of Zn-CA in the presence of glutathione. (A – E) 1 µM apo-CA was
reacted with (A) 2.5 µM, (B) 5 µM, (C) 10 µM, (D) 20 µM and (E) 40 µM Zn2+ in the presence of 1
mM GSH. The reactions were monitored in the presence of dansyl amide. Fluorescence spectra
were recorded at excitation wavelength 320 nm and emission wavelength 400 – 600 nm. (F)
Change of fluorescence at 460 nm during the reactions with time.
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3.4.2. Effect of glutathione on proteome-mediated reconstitution of Zn-CA
The presence of proteome was previously found to significantly decrease the rate of Zn-CA
reconstitution (section 3.2.6 and figure 22). Here, we investigated if glutathione could modify
the rate of proteome-mediated reconstitution of Zn-CA. The experiments were based on the
hypothesis that the presence of GSH may set up an equilibrium between Proteome•Zn and ZnSG, providing a kinetic pathway through Zn-SG that speeds up the metal transfer apo-CA.
To test the effect, 1 µM apo-CA was reacted with 2 µM Zn2+ in the presence Proteome (5.6 µM
native Zn2+) and 1 mM glutathione. As a control experiment, the reaction was repeated without
glutathione. As anticipated, the control reaction resulted in a slow reconstitution of Zn-CA
(Figure 36 A and C).
Proteome-SH + Zn2+  Proteome-S•Zn + H+
Proteome-S•Zn + apo-CA + H+  Proteome-SH + Zn-CA

(67)
(slow)

(68)

Interestingly, the introduction of 1 mM glutathione to the reaction significantly enhanced the
rate of Zn-CA (Figure 36 B and C), suggesting an alternative and faster route of proteomemediated zinc transfer to apo-CA in the presence of glutathione. Probably, as hypothesized
above, there exists a zinc transfer equilibrium between Proteome and glutathione, and
eventually, glutathione facilitates the transfer of zinc to apo-CA to reconstitute Zn-CA.
Proteome-S•Zn + GSH  Proteome-S•Zn-SG + H+

(69)

Proteome-S•Zn-SG + H+  Proteome-SH + Zn-SG

(70)

Zn-SG + apo-CA + H+  Zn-CA + GSH (fast)

(71)
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Figure 36. Effect of glutathione on proteome-mediated reconstitution of Zn-CA. (A and B) 1
µM apo-CA was reacted with 2 µM Zn2+ and Proteome containing 5.6 µM native Zn2+ in the
absence (A) or presence of 1 mM GSH (B). The reaction was monitored using dansyl amide (DA).
Fluorescence spectra were recorded using excitation wavelength 320 nm and emission
wavelength 400 – 600 nm. (C) Change of fluorescence at 460 nm of both reactions with time.
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The effect of glutathione on Proteome-mediated Zn-CA reconstitution was tested another way.
Cell lysate was collected from 2x108 LLC-PK1 cells and filtered using a Centricon 3K molecular
weight cut-off filter to separate the high molecular weight (HMW) and low molecular weight
(LMW) fractions. Since LLC-PK1 cells contain undetectable amount of metallothionein under
basal condition, the isolated high molecular weight (HMW) fraction contains only high
molecular weight soluble proteins. By contrast, the low molecular weight (LMW) fraction is a
collection of all small molecules of cells, including glutathione. Subsequently, the HMW fraction
was split into three aliquots. Each aliquot contained 8.8 µM native Zn2+. One aliquot of HMW
fraction was reacted with 1 µM apo-CA and 1 µM exogenous Zn2+. As expected, a slow rate of
Zn-CA was observed in the presence of high molecular weight proteome fractions (Figure 37 A
and D). Another aliquot of HMW fraction was reacted the same way, except that the LMW
fraction was added to reaction mixture. A dramatic increase in rate was observed in the LMWtreated reaction (Figure 37 B and D), indicating that cellular small molecules, including
glutathione, played a significant part in cellular zinc trafficking to generate native Zn-proteins.
The third aliquot of HMW fraction was reacted with 1 µM apo-CA and 1 µM exogenous Zn2+ in
the presence of 1 mM exogenous glutathione. Interestingly, in this case, an identical increase of
reaction rate as in the second case was observed (Figure 37 C and D), confirming that
glutathione present in LMW fraction was implicated in the rate enhancement in the second
reaction.
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Figure 37. Zn-CA reconstitution in the presence of high molecular weight (HMW) and low
molecular weight (LMW) fractions. (A – C) 1 µM apo-CA was reacted with 1 µM exogenous Zn2+
in the presence of (A) high molecular weight (HMW) fraction isolated from LLC-PK1 cells, or (B)
HMW and LMW fractions, or (C) HMW fraction and 1 mM exogenous GSH. The reaction
progress was followed using dansyl amide (DA). Fluorescence spectra were recorded using
excitation wavelength 320 nm and emission wavelength 400 – 600 nm. (D) Change of
fluorescence at 460 nm of the reactions with time.
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3.4.3 Effect of glutathione on Zn-CA reconstitution in presence of proteome and Zn7-MT
Having found that glutathione facilitated proteome-mediated reconstitution of Zn-CA, next we
probed its effect on Zn-CA regeneration in presence of both proteome and Zn7-metallothionein.
The rate and extent of reaction of Zn7-MT with apo-CA was reduced by the addition of 1 mM
GSH, like in the presence of Proteome. But the impact of GSH was different when Proteome
was part of the reaction.
1 µM apo-CA was reacted with 2 µM Zn7-MT and proteome containing 5.6 µM native Zn2+
followed by the addition of 1 mM GSH. The control experiment did not include any glutathione.
As seen before, the control experiment yielded the slow regeneration of Zn-CA in the presence
of both proteome and metallothionein (Figure 38 A and C). This slow reaction can be explained
by referring to the previous analysis of the reaction of Zn 7-MT with apo-CA in the presence of
Proteome which suggested two possible mechanisms by which Proteome could retard the
reconstitution reaction.
Possibility 1.
Zn7-MT + Proteome-SH  Zn6-MT + Proteome-S•Zn + H+
Proteome-S•Zn + apo-CA + H+  Proteome-SH + Zn-CA (slow)

(72)
(73)

In this scheme, the Proteome competes for Zn2+ bound to MT and then reacts with apo-CA, like
Zn-MT. If Proteome-S•Zn reacts slower with apo-CA than Zn7-MT, the observed reaction rate
will decrease.
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Possibility 2.
Proteome-SH + Zn7-MT  Proteome-S•Zn7-MT + H+
Zn7-MT + apo-CA  Zn6-MT +Zn-CA (slow)

(74)
(75)

According to this mechanism, the plausible intermediate in reaction 74 above, Proteome-S•Zn7MT, becomes a quantitatively important product in the equilibrium of reaction 76:
Zn7-MT + Proteome-SH  Proteome-S•Zn7-MT  Zn6-MT + Proteome-S•Zn + H+

(76)

It is then hypothesized that it is unreactive or relatively unreactive with apo-CA.
Surprisingly, in the presence of 1 mM glutathione, a large increase in the rate of Zn-CA
reconstitution was observed (Figure 38 B and C), indicating a possible faster route of zinc
transfer to apo-CA that involved glutathione. This mechanism might include the formation of a
ternary complex, Proteome-S•Zn7-MT, which then reacts with GSH and produces a new ternary
complex, GS•Zn7-MT. Eventually, zinc is transferred in a faster rate from the newly formed
adduct to apo-CA to regenerate Zn-CA.
Proteome-SH + Zn7-MT  Proteome-S•Zn7-MT
Proteome-S•Zn7-MT + GSH  Proteome-SH + GS•Zn7-MT
GS•Zn7-MT + n(apo-CA)  n(Zn-CA) + Zn7-n-MT + GSH (fast)
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Figure 38. Effect of glutathione on Zn-CA reconstitution in the presence of both proteome and
Zn7-MT. (A and B) 1 µM apo-CA was reacted with 2 µM Zn7-MT and proteome containing 5.6
µM native Zn2+ in the absence (A) or presence of 1 mM GSH (B). The reaction was monitored
using dansyl amide (DA). Fluorescence spectra were recorded using excitation wavelength 320
nm and emission wavelength 400 – 600 nm. (C) Change of fluorescence at 460 nm of both
reactions with time.
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A previous study by Brouwer et al demonstrated that GSH forms an adduct with Zn 7-MT [106].
On the basis of molecular modeling, they suggested that GSH associates specifically with one of
the crevices in the α-domain of Zn7-MT. In so doing, it may compete with Proteome-SH for
binding to the α-domain Zn4S11 cluster, preventing the formation of Proteome-S-Zn7-MT. If this
mechanism is correct, GS-Zn7-MT retains its reactivity toward apo-CA.
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3.4.4 Effect of inhibition of cellular glutathione synthesis on zinc trafficking
We have demonstrated that glutathione enhanced the rate of formation of Zn-CA from apo-CA
in the presence of either Proteome•Zn or Proteome plus Zn7-MT. Thus, we have explored the
effect of glutathione synthesis on cellular zinc trafficking. To inhibit cellular glutathione
synthesis, LLC-PK1 cells were treated with buthionine sulfoximine (BSO) for 24 hours. BSO
inhibits gamma-glutamylcysteine synthetase, the enzyme necessary to catalyze the first step of
glutathione synthesis, and thus greatly reduces the cellular level of glutathione over this time
period [107]. First, the toxicity of BSO to LLC-PK1 cells was examined by staining BSO-treated
and untreated cells with trypan blue dye. According to Figure 39, even at a concentration as
high as 200 µM of BSO, the cell viability was found to be greater than 90%. Therefore, to study
the impact of BSO on cellular zinc trafficking by inhibiting glutathione synthesis, LLC-PK1 cells
were treated with 100 µM BSO for 24 hours. The efficiency of BSO in inhibiting glutathione
synthesis in LLC-PK1 cells was also tested. Following the treatment of 2x108 LLC-PK1 cells with
100 µM BSO (cell viability ≥, cell 90%, Figure 39), supernatant was collected and filtered to
separate the high molecular weight (HMW) and low molecular weight (LMW) fractions. Using
the DTNB assay, the sulfhydryl content in both fractions was quantified. As a control, the similar
procedure was done with 2x108 LLC-PK1 cells untreated with BSO. According to DTNB assay, 8
nmol/107 cells of sulfhydryl groups found in high molecular weight (HMW) fraction of BSO
treated cells, as well as 8 nmol/107 cells in that of control cells, meaning that BSO treatment did
not have any noticeable effect on proteomic sulfhydryl groups (Figure 40). However, a dramatic
change was observed in low molecular weight (LMW) fractions. The LMW fraction of untreated
cells contained 29 nmol/107 cells of sulfhydryl content. By contrast, only 0.4 nmol/107 cells was
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detected in that of BSO-treated cells. That is, the low molecular weight sulfhydryl content was
almost completely abolished following BSO treatment. This result confirmed the effectiveness
of BSO in reducing the cellular level of glutathione.
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Figure 39. Toxicity of buthionine sulfoximine (BSO) to LLC-PK1 cells. 1 x 107 LLC-PK1 cells were
treated with various concentration of BSO dissolved in culture medium for 24 hours.
Subsequently, cells were released by trypsin-EDTA treatment and resuspended in DPBS. The cell
suspension was then stained with trypan blue at 1:1 ratio. Number of live and dead cells were
counted using a hemacytometer.
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Figure 40. Comparison of sulfhydryl content in BSO-treated and control cells. 2 x 108 LLC-PK1
cells were treated with 100 µM BSO for 24 hours. Afterwards, cells were washed and cell
supernatant was collected via sonication and centrifugation. Cell lysate was then filtered using
a Centricon 3K molecular weight cut-off filter separate high molecular weight (HMW) and low
molecular weight (LMW) fractions. The sulfhydryl content in each fraction was quantified using
DTNB assay.
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We then investigated if the reduction of glutathione level by BSO treatment had any effect on
the cellular zinc status. To test this, both BSO treated and untreated (control) 2 x 10 7 LLC-PK1
cells were reacted with 20 µM TSQ, a fluorescent zinc sensor that (i) reacts with Zn2+ to form
Zn(TSQ)2 with an emission wavelength maximum of 492 nm and (II) can also form ternary
adducts with proteomic Zn2+ characterized by a wavelength maximum of 470-475 nm [76-78].
In the case of control cells, as anticipated, a slow increase of fluorescence at 470 nm was
observed (Figure 41 A), indicative of the formation of ternary complex of TSQ and native Znproteins, TSQ-Zn-protein.
Zn-Proteome + TSQ  TSQ-Zn-Proteome

(slow)

It has been previously reported that TSQ reacts slowly with about 25% of native Zn-proteins
and generates TSQ-Zn-protein ternary complex with a signature fluorescence spectrum
centered at 470 nm [76-78]. Surprisingly, the reaction of BSO-treated cells and TSQ produced a
much faster and greater fluorescence enhancement with an emission maximum of 470 nm
(Figure 41 B). This remarkable 2.7x increase of fluorescence relative to the same number of
control cells suggested that BSO treated cells appeared to contained a significant amount of
adventitiously bound proteomic zinc, Proteome-S•Zn, with which TSQ reacted to form
proteome-S•Zn-TSQ ternary complex and resulted in a faster increase of fluorescence at 470
nm.
Proteome-S•Zn + TSQ  Proteome-S•Zn-TSQ (fast)
The apparent generation of proteome-S•Zn following inhibition of glutathione synthesis by BSO
treatment suggested that under basal cellular conditions, some cellular zinc binds to
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glutathione in the steady state of zinc trafficking and, thus, is involved in mediating the
trafficking of Zn2+ to apo-Zn protein binding sites. As glutathione level in cell drops, the GSH
dependent pathway is blocked (Figure 41):
Zn2+outside cell  Zn2+inside cell  Proteome•Zn  Zn(SG)n+  Zn-Protein

(80)

As a consequence, Zn2+ begins to accumulate in the Proteome, bound to proteomic non-specific
sites. Overall, this finding strongly supported the novel hypothesis that glutathione plays a
critical role in cellular zinc trafficking leading to the formation of native Zn-proteins. Since cells
were still able to divide and acquire their required set of Zn-proteins for cell proliferation even
in the almost complete absence of GSH, we hypothesized that the apparent elevation in
Proteome•Zn supported its capacity to directly supply Zn2+ to apo-Zn proteins.
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Fluorescence intensity @ 470 nm
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Figure 41. Reaction of BSO-treated cells with TSQ. (A) Control experiment: 2x107 LLC-PK1 cells
resuspended in DPBS were reacted with 20 µM TSQ for 30 min. Fluorescence spectra were
recorded using excitation wavelength 370 nm and emission wavelength 400 – 600 nm. (B) 2x107
LLC-PK1 cells were treated with 100 µM BSO for 24 hours. Thereafter, cells resuspended in DPBS
were treated with 20 µM TSQ for 30 min. (C) Change of fluorescence at 470 nm with time for
both reactions.
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The reaction of isolated Proteome from BSO-treated cells with TSQ showed a similar faster
enhancement of fluorescence in comparison with control Proteome, as was observed in the
study of the reaction of TSQ with whole cells (Figure 42). The result of isolated proteome
experiment further supported the hypothesis that glutathione-bound zinc plays an important
role in cellular zinc trafficking, and thus inhibition of its synthesis in cells by BSO resulted in the
non-specific binding of zinc to proteome.
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Figure 42. Reaction of TSQ with proteome isolated from BSO-treated cells. (A and B) Isolated
proteome from untreated LLC-PK1 cells (A) or treated with 100 µM BSO for 24 hours (B) was
reacted with 20 µM TSQ for 30 min. Fluorescence spectra were recorded using excitation
wavelength 370 nm and emission wavelength 400 – 600 nm. (C) Change of fluorescence at 470
nm with time for both reactions.
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The amount and distribution of zinc in BSO-treated and control cells were determined by
Sephadex G-75 chromatography. Over the course of 24 h both sets of cells grew at nearly the
same rate, approximately doubling their numbers (1.9x and 1.8x respectively). When the cell
supernatant collected from 2x108 LLC-PK1 cells previously treated with 100 µM BSO was
fractionated using Sephadex G-75 chromatography, a significant increase in proteome zinc was
observed, as compared with that from same number of control cells (Figure 43). This is
consistent with the fluorescence enhancement observed in the reaction of TSQ with BSOtreated cells. Overall, BSO-treated cells contained 2.1x of the total zinc measured in control
cells. On the basis of the concentration of proteomic Zn in the control cells (58 nmol/108 cells),
the ratio of Proteome•Zn to Zn-Proteome was 2.3. For comparison, in earlier experiments, 1
µM Zn2+ was added to Proteome containing 3-6 µM Zn2+, resulting in a ratio of Proteome•Zn to
Zn-Proteome in the range of 0.16 – 0.33. Thus, the cellular experiment has resulted in a
concentration of Proteome•Zn that is ca. 10 times that of the in vitro experiments.
Only 1.7 nmol/107 cells was required for native Zn-protein synthesis during cell proliferation
(control cells). Therefore, the BSO-exposed cells had obtained 1.9 nmol/107 cells of additional
zinc from the extracellular medium in the form of Proteome•Zn. As well, a noticeable pool of
metallothionein zinc was present in BSO-treated cells, implying that the inhibition of
glutathione synthesis and the consequent increase in intracellular Zn2+ has induced the
upregulation of metallothionein synthesis. Hypothetically, preventing glutathione synthesis has
upregulated the cell membrane ZIP transporter that shuttles extra zinc into cytosol causing
both the appearance of Zn-MT and the huge increase in Proteome•Zn.
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Figure 43. Sephadex G-75 gel filtration chromatography of lysate from BSO-treated cells.
2x108 LLC-PK1 cells were treated with 100 µM BSO for 24 hours. Cells were then washed,
sonicated and centrifuged to collect the lysate, which was then loaded onto a Sephadex G-75
column and eluted with 20 mM degassed Tris buffer, pH 7.4. The collected fractions were
analyzed for zinc content using ICP-MS. A control experiment was done with cells without any
treatment with BSO.
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3.4.5 Effect of BSO on Proteome-mediated reconstitution of Zn-CA
The effect of glutathione depletion by BSO on the reconstitution of Zn-CA from apo-CA was
investigated using Proteome•Zn from BSO-treated cells as the source of Zn2+. First, control
proteome isolated from untreated LLC-PK1 cells was reacted with 1 µM apo-CA in the presence
of 1.6 µM dansyl amide. Since the control proteome contained only native Zn2+ and no added
Zn2+, no detectable reconstitution of Zn-CA was observed, as expected. Even in the presence of
1 mM glutathione (GSH), control proteome did not support any reconstitution of Zn-CA,
suggesting that no adventitiously bound proteomic zinc is available for glutathione to mediate
its transfer to apo-CA and reconstitute Zn-CA.
Zn-proteins + apo-CA  No reaction

(81)

Zn-proteins + apo-CA + GSH  No reaction

(82)

In contrast, when the reaction was carried out in presence of proteome collected from BSOtreated cells, a rapid increase of fluorescence at 460 nm was observed, indicating reconstitution
of Zn-CA (Figure 44). Interestingly, the addition of GSH further enhanced the rate of
reconstitution, consistent with experiments with the reactivity of exogenously added proteomic
Zn2+ with apo-CA.
This result completed the confirmation of our hypothesis that reduction of cellular glutathione
level caused adventitious zinc binding to the Proteome that was available for/reactive with the
reconstitution of apo-Zn proteins such as apo-CA. According to the results, the loss of GSH
content interrupted the steady-state trafficking pathway of Zn2+ that is present in cells
containing normal, mM concentrations of GSH. Because BSO-treated cells were still competent
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to divide and, in the process, acquire their requisite amount of Zn 2+ for the new synthesis of Znproteins from the extracellular medium, we hypothesized that the much elevated
concentrations of Proteome•Zn and Zn-MT that exist in these cells become the proximate
sources of Zn2+ for Zn-Protein constitution (reaction 83):

2+

Zn

outside cell

2+

 Zn

inside cell

 Proteome•Zn  Zn-Protein
Zn-MT
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(83)
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Figure 44. Effect of glutathione inhibition on proteome-mediated Zn-CA reconstitution. (A)
Proteome isolated from 100 µM BSO treated cells was reacted with 1 µM apo-CA in the
presence of 1.6 µM dansyl amide. Fluorescence spectra were recorded at excitation wavelength
320 nm and emission wavelength 400 – 600 nm. (B) Reaction (A) was repeated in the presence
of 1 mM added glutathione. (C) Change of fluorescence at 460 nm for the reactions with control
and BSO-treated proteome in absence or presence of 1 mM added glutathione.
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4. Discussion
Zinc is the second most abundant transition metal in living organisms [8]. A eukaryotic cell
contains 100 – 500 mM zinc [9, 10]. Most of the cellular zinc is bound to thousands of proteins,
in which it functions as either a structural or a catalytic cofactor [4, 14-16]. Of the proteins in
which zinc acts a structural cofactor, zinc finger transcription factors are common. These zinc
binding proteins bind promotor regions of DNA and aid the initiation of DNA transcription. As a
catalytic cofactor, zinc constitutes the active site of a number of important enzymes, e.g.,
carbonic anhydrase, alcohol dehydrogenase, alkaline phosphatase, etc. Apart from structural
and catalytic functions, according to various reports, zinc can also act as a secondary messenger
and thus has a signaling function [53-57]. Due to these numerous important functions of zinc,
its proper balance in cells needs to be maintained. Both deficiency and excess of zinc can cause
many biological disorders. Deficiency is related to developmental defects, growth inhibition,
loss of immune function. However, despite having critical roles in many biological processes,
zinc trafficking and signaling mechanisms are still poorly understood. In general, zinc trafficking
refers to the pathway of uptake of zinc into cytosol through the plasma membrane and its
subsequent transport to apo-proteins to make native Zn-proteins. Alternately, trafficking refers
to the molecular mechanisms by which labile zinc becomes available to act as a signaling
chemical in various processes. Some studies have concluded that metallothionein acts a
thermodynamic sink for the incoming flux of zinc, which, in turn, transfers zinc to apo-proteins
for the generation of native Zn-proteins [15, 31, 37, 38, 45]. However, the evidence of
metallothionein role in zinc trafficking remains meager. The fact that zinc trafficking remains
intact in MT-null cells demonstrates that metallothionein is not required for functional zinc
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trafficking [52]. Therefore, a detailed understanding of cellular chemistry of zinc is needed to
understand the cellular zinc trafficking and signaling mechanisms, which encourages
researchers to study the interaction of zinc with cellular components.
Maret et al examined the interaction of zinc with cellular proteome in the presence of a
colorimetric zinc sensor, Zincon, which displays a red-shift of absorption maximum from 490
nm to 620 nm upon binding zinc (Figure 6) [9]. They discovered that the cellular Proteome has a
zinc buffering capacity, meaning that proteome has numerous adventitious zinc binding sites
that can bind zinc in equilibrium fashion. In their study, a titration of the Proteome with Zn2+ in
the presence of ZI demonstrated the Proteome’s buffering capacity. When extra zinc was added
to the Proteome in the presence of ZI, Zn-ZI failed to form in the initial part of the titration as
indicated by the initial absence of 620 nm absorbance (Figure 5). Beyond the initial zinc
buffering region of Proteome, a gradual increase of absorbance was observed with the addition
of more zinc (Figure 5), which was interpreted by Maret group as the formation of the Zn-ZI
complex. However, they did not provide any explanation for the fact the slope of titration curve
reflecting the increase of absorbance in presence of Proteome was very different from that in
the absence of Proteome (Figure 5). We hypothesized that the Proteome contains two kinds of
adventitious zinc binding sites relative to Zincon higher affinity and lower affinity zinc binding
sites. The high affinity sites relative to Zincon form the buffering region and outcompete Zincon
for the added zinc. We hypothesized that, the low affinity binding sites form ternary
complexes, Proteome•Zn-ZI, with zinc and Zincon. Therefore, the increase of absorbance
following the saturation of Proteome’s zinc buffering region was not due to the formation of
Zn-ZI complex, but for proteome•Zn-ZI ternary complex.
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To test the hypothesis that Proteome’s relatively low affinity, non-specific zinc binding sites
form ternary complexes with added zinc and Zincon showing the linear increase of absorbance,
we repeated the titration experiment done by Maret’s research group. As we titrated proteome
isolated from LLC-PK1 cells with extra zinc in the presence of ZI, we observed a similar zinc
buffering region, in which no change of ZI absorbance appeared (≤10 µM added zinc), indicating
Proteome’s relatively high affinity, adventitious zinc binding sites outcompeted Zincon for the
initially added zinc (Figure 7). Like Maret’s research group, we also found a gradual increase of
absorbance, as more zinc was added following the saturation of the Proteome’s buffering zone,
and the slope of the titration curve was significantly different from control titration curve, i.e.,
titration of ZI with zinc in absence of Proteome. Additionally, the amount of zinc needed to
complete the titration in the presence of Proteome was much higher than that for control
titration, clearly indicating that there existed a competition between Proteome’s relatively low
affinity zinc binding sites and ZI for the added zinc. Also, the final absorbance reached after the
titration was only about 40% of that observed in the titration of the same concentration of ZI
with Zn2+ in the absence of Proteome. Most surprisingly, the increase of absorbance beyond the
buffering region proteome was accompanied by absorption maximum of 640 nm. Since Zn-ZI
complex shows absorbance at 620 nm, the absorption maximum of 640 nm clearly suggested
that the absorbing species is not Zn-ZI complex. Interestingly, as the final reaction mixture of
titration experiment was filtered using 3K molecular weight cut-off filter, almost all of the
absorbance and zinc were located in the retentate fraction (Figure 8). Furthermore, the
absorption spectra of the retentate fraction was centered at 640 nm, and much of this 640 nm
absorbance was abolished when reacted with TPEN, (N,N,N’,N’-tetrakis(2-pyridinylmethyl)-1,2143

ethanediamine), a strong zinc chelator. Together, these findings were consistent with the
hypothesis that proteome’s relatively low affinity zinc binding sites make ternary complexes,
proteome•Zn-ZI, with zinc and ZI, characterized by the absorption maximum of 640 nm.
Proteome + Zn2+  Proteome•Zn (higher and lower affinity
binding buffering region)

(84)

Proteome•Zn + ZI  Proteome•Zn-ZI (lower affinity binding
sites, 640 nm absorbance)

(85)

When the final reaction mixture of titration experiment was reacted with TSQ, the 640 nm
absorbance declined (Figure 9). A fluorescent sensor, TSQ forms ternary complexes with both
native Zn-proteins (TSQ-Zn-proteins) and adventitiously bound zinc to proteome (proteome•ZnZI) (ref). Therefore, the decline of 640 nm absorbance following the introduction of TSQ to the
reaction mixture, was consistent with the hypothesis that TSQ replaced ZI from proteome•Zn-ZI
ternary complex and generated proteome•Zn-TSQ ternary complex.
Proteome•Zn-ZI + TSQ  Proteome•Zn-TSQ + ZI

(86)

However, this reaction and, indeed, all of the findings might be consistent with a reaction in
which Zn-ZI reacted with the Proteome at sites other than ones that can bind Zn2+ through nonspecific interactions between ZI and proteomic side chains and backbone.
Proteome + Zn2+ + ZI  Proteome•ZI-Zn

(87)

The details of the reaction of TPEN with the product of the titration help to distinguish the
nature of its structure. TPEN binds Zn2+ with a conditional stability constant at pH 7.4 that is
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about 10 orders of magnitude larger than that of ZI. Yet, according to Figure 8, the exchange of
Zn2+ between ZI and TPEN was not stoichiometric. In fact, a large excess of TPEN was needed to
complete the reaction. This result suggested that Zn-ZI was not bound to Proteome, primarily
as a Proteome•ZI adduct which would likely leave Zn2+ in ZI-Zn sterically open for reaction with
TPEN:
Proteome•ZI-Zn + TPEN  Zn-TPEN + Proteome + ZI

(88)

Instead, in a ternary complex mediated by Zn2+, Proteome•Zn-ZI, the zinc ion may be sterically
buried and kinetically hindered in its reaction with TPEN:
Proteome•Zn-ZI + TPEN  Zn-TPEN + Proteome + ZI

(89)

We considered the possibility that the appearance of the 640 nm absorbance spectral
maximum during the titration of ZI with zinc in the presence of Proteome was due to the nature
of proteomic environment in which Zn-ZI was located, but not because of ternary complex
formation. Figure 13 shows the spectra of Zn-ZI in a range of solvents with different dielectric
constants. Although solvents markedly perturbed the spectrum of Zn-ZI, none of them
resembled the simple red-shift seen in the reaction with Proteome (Figure 13). This finding
further strengthened the hypothesis that ZI forms ternary complex, proteome•Zn-ZI, with zinc
bound to relatively lower affinity adventitious sites of proteome.
Pre-treatment of proteome with N-ethylmaleimide (NEM), a sulfhydryl binding reagent,
significantly reduced its high affinity, zinc buffering capacity (Figure 14). A similar finding was
made in studies that employed the fluorescent zinc probe, Newport Green [85]. This
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experiment demonstrated that proteomic sulfhydryl groups are centrally involved in generating
its high affinity, zinc buffering capacity.
Proteome-(SH)n + Zn2+  Proteome-Sn•Zn + nH+

(90)

Presumably, when bound to these sites, Zn2+ is coordinated with thiolate and perhaps some
other ligands such that it is unavailable to form ternary complexes with ZI.
Having shown that the Proteome has many relatively lower affinity, non-specific zinc binding
sites that can form ternary complexes with added zinc and Zincon, we used bovine serum
albumin (BSA) as a model protein that binds Zn2+ with a moderate stability constant at pH 7.4
and whether ZI reacts with BSA and Zn2+ similarly to its reaction with Proteome and Zn2+. BSA
has been reported to contain a number potential zinc binding sites including a primary one that
in involved in the transport of plasma Zn2+, and therefore, we hypothesized that BSA will form
ternary complex with ZI and added zinc via its potential zinc binding sites [100]. As anticipated,
titration of ZI with zinc in the presence of BSA resulted in the increase of absorbance with an
absorption maximum of 640 nm. In addition, as the final reaction mixture was filtered using a
3K molecular weight cut-off filter, most of the 640 nm absorbance and zinc were located in the
retentate fraction (Figure 10). Taken together, these results indicated that like proteome, the
model protein, BSA, formed ternary complexes with added zinc and ZI.
To summarize the findings from Zincon study, Proteome has many adventitious zinc binding
sites that are implicated in binding more zinc than needed for native Zn-proteins synthesis,
primarily via sulfhydryl groups. Relative to the zinc binding affinity of Zincon, these proteomic
adventitious zinc binding sites can be classified into two groups higher affinity and lower affinity
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sites. The higher affinity proteomic sites, which contain sulfhydryl ligands, outcompete Zincon
for the added zinc, while the low affinity sites form ternary complexes, Proteome-S•Zn-ZI.
The zinc binding constants of native Zn-proteins have been reported in the range of 109 – 1012
M-1, while Proteome’s high affinity, non-specific zinc binding constants were calculated to be on
the order of 1010 M-1 [11, 12]. The presence of such high affinity, non-specific sites for Zn2+ in
the cell suggests that free Zn2+ concentration must be very small and probably not significant in
mechanisms of cellular zinc trafficking. Therefore, we hypothesized that these high affinity,
adventitious zinc binding sites of Proteome play a critical role in the intracellular trafficking of
zinc and zinc signaling. Namely, following transport of zinc across the plasma membrane, zinc
first binds to various adventitious sites within the Proteome and then is transferred to the
various apo-zinc proteins to generate native Zn-proteins. Thus, Proteome acts as an
intermediate in cellular zinc trafficking and signaling.
Proteome-SH + Zn2+  Proteome-S•Zn + H+
Proteome-S•Zn + apo-Proteins  Proteome-SH + Zn-Proteins

(91)
(92)

To test the hypothesis, LLC-PK1 cells were treated with excess zinc and the distribution of excess
zinc among the cellular components was examined. The result of the experiment showed that
only 1% of the added zinc made its way into cytosol, of which 73% was captured by the induced
metallothionein, Zn7-MT and 26% was bound to high molecular weight Proteome (Figure 15).
When the Proteome isolated from these cells was reacted with zinc fluorescent sensor, TSQ, a
rapid enhancement of fluorescence centered at 470 nm was detected (Figure 17). This
indicated that the excess zinc is adventitiously associated with proteome, denoted as
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Proteome•Zn. As reported, TSQ reacts slowly with 15-20% native Zn-Proteins to form ternary
complex, TSQ-Zn-Proteins, with slow increase of 470 nm fluorescence [76-78]. In contrast, TSQ
exhibits a rapid increase of fluorescence with the same emission maximum when it reacts with
zinc adventitiously bound to the Proteome, Proteome•Zn (reaction 93).
Proteome•Zn + TSQ  Proteome•Zn-TSQ

(93)

Another possibility of the form of extra zinc associated with Proteome was the ternary complex,
Proteome-S-Zn7-MT, between proteome and Zn7-MT. However, since Zn7-MT does not display
any reactivity with TSQ, the above-mentioned TSQ reaction that produced rapid fluorescence
enhancement at 470 nm ruled out this possibility. Together, these results supported our
hypothesis that following cellular uptake, zinc binds to various adventitious sites of Proteome
as Proteome•Zn, as well as to the induced metallothionein, Zn7-MT.
Next, we examined if Proteome-bound zinc can be transferred to precursor apo-proteins to
make native Zn-Proteins. For this study, we chose Zn-carbonic anhydrase (Zn-CA) as a model Znprotein because of its known structure (Figure 18), zinc stability constant (1011.4 at pH 7) and
availability, and probed if Proteome can transfer its non-specifically bound zinc to apo-carbonic
anhydrase (apo-CA) and regenerate Zn-CA (Reaction 33) [29]. As a marker of Zn-CA
reconstitution, we employed dansyl amide (DA), which shows no reactivity with either free zinc
or apo-CA, but makes a ternary complex with Zn-CA and exhibits fluorescence enhancement,
along with a blue shift from 540 nm to 460 nm (Reaction 94) [93].
Zn-CA + DA  DA-Zn-CA
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(94)

The reconstitution of Zn-CA from the reaction of apo-CA and free zinc was found to be relatively
fast (Figure 19). A stoichiometric reaction between apo-CA and free zinc was completed in 5 –
10 minutes.
Proteome-mediated reconstitution of Zn-CA was tested by reacting pre-formed Proteome•Zn
and apo-CA under conditions in which Zn2+ was bound only to high affinity proteomic sites. The
gradual increase of 460 nm fluorescence indicated that zinc was transferred from proteome to
apo-CA and, thus, that Zn-CA was reconstituted (Figure 22). However, the rate of Proteomemediated Zn-CA reconstitution was slow. While in the absence of Proteome, 100%
reconstitution occurred in few minutes, it required several hours only for 50% reconstitution to
happen in presence of Proteome (Figure 22). Clearly, binding of zinc to Proteome slowed down
the rate of reaction. This was attributed to two factors: first Zn 2+ was firmly bound with ligands
other than water that had to be exchanged with the imidazole ligands of apo-CA during the
reaction. Second, the proteomic zinc binding sites presented significant steric hindrance to
apo-CA during it reaction with Proteome•Zn. The latter factor would be significant if the overall
reaction were second order, first order in Proteome•Zn and first order in apo-CA. Higher
Proteome concentration at constant Zn2+ concentration further slowed down the kinetics of the
reaction (Figure 23), which was understandable, because increased Proteome concentration
presented a higher number of high affinity adventitious zinc binding sites and, as a
consequence, made zinc less available for apo-CA. By contrast, pre-incubation of proteome with
N-ethylmaleimide (NEM), a sulfhydryl binding reagent, caused a large increase in rate of
proteome-mediated Zn-CA reconstitution (Figure 24), further confirming that high affinity,
proteomic sites primarily bind zinc via sulfhydryl groups. As a result of blocking of sulfhydryl
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groups, zinc probably became bound to weaker ligands, e.g., imidazole and carboxylate groups,
favoring the formation of Zn-CA.
In order to further understand the possible cause of slow and incomplete reconstitution of ZnCA by Zn2+ in presence of the Proteome, we considered the possibility that perhaps under
native, cellular condition, zinc binds to unfolded apo-CADenatured (apo-CAD) to generate folded,
native Zn-CA. For our in-vitro experiments, apo-CANative (apo-CAN) was used in the absence of
denaturants. It adopts the folded structure of Zn-CA (ref). As such, apo-CAD may be more
favorable thermodynamically for the reconstitution of Zn-CA if folding is coupled to zinc
binding:
apo-CAD  apo-CAN (energetically favorable)

(95)

apo-CAN + Zn2+  Zn-CAN

(96)

(energetically favorable)

apo-CAD + Zn2+  Zn-CAN

(97)

Similarly, the pre-folded apo-CA may also add a steric factor to the reconstitution process that
slows down the kinetics of the reaction. That is, since apo-CAN adopts the native conformation
of Zn-CA, the ligand binding site for Zn2+ is also pre-formed and inflexible. Considering the
multiple, intermediate ligand substitution steps that must be involved during the complex
ligand substitution of three imidazole ligands from apo-CAN for several ligands that bind Zn2+ in
Proteome•Zn. However, when the proteome-assisted Zn-CA regeneration was conducted with
denatured, unfolded apo-CA, the rate of the reaction was, in fact, even slower than that with
pre-folded apo-CA (Figure 28). Also, the extent of Zn-CA reformation from denatured apo-CA
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was only 50% of native apo-CA. We were unclear as to how to interpret these results without
further experimentation and decided to focus on the reactions with apo-CAN.
The basic reaction was repeated with systemic variation in Proteome concentration. As seen in
Figure 23, increasing the Proteome concentration decreased the extent of reaction of
Proteome•Zn with apo-CA. Using the overall reaction,
Proteome•Zn + apo-CA  Zn-CA + Proteome

(Keq)

(98)

the conditional log stability constant at pH 7.4 of Zn-CA (11.4), and the total concentrations of
high affinity binding sites for Zn2+ within the Proteome (1.5x the concentration of Zn-proteins),
we first calculated Keq for each reaction and then secondarily KProteome•Zn from the equation,
Keq = KZn-CA/KProteome•Zn. A value of 10.5 ± 0.3 was obtained, which is in good agreement with the
value of 10.2 obtained from a previous study (unpublished data).
Next, we investigated the kinetics of the reaction. A pseudo-first order rate study was done
using large excess of apo-CA relative of Proteome•Zn, According to Figure 29, the rate of
Proteome-mediated Zn-CA reformation reaction was calculated to be strictly second order,
indicating that the reaction is a straight-forward ligand substitution between Proteome•Zn and
apo-CA, with no first-order rate limiting step, such as dissociation of Zn2+ from proteomic sites.
The bimolecular character of the reaction supports the view that the slow and partial
reconstitution of Zn-CA in the presence of Proteome•Zn results from the large steric hindrance
that occurs when two macromolecules must get into proper steric proximity to exchange
ligands.
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Having observed the slow and incomplete Proteome-assisted reformation of Zn-CA, we
hypothesized that besides high molecular weight proteome, other cellular components, such as
metallothionein (Zn7-MT) and glutathione (GSH), etc. are involved in Proteome-mediated zinc
trafficking to make native Zn-Proteins. When fully saturated, each metallothionein molecule
has seven zinc ions bound to two thiolate clusters with stability constants of 1010-11 [37, 38]. By
contrast, glutathione does not have large binding constant, but it exists in cells at relatively high
concentrations [85]. Due to these facts, it was hypothesized that their involvement in cellular
zinc trafficking possibly makes the formation of Zn-Proteins mediated by proteome kinetically
faster. To examine this hypothesis, the impact of metallothionein and glutathione on the
kinetics of Proteome-mediated Zn-CA regeneration was studied.
As was observed in Proteome-mediated reaction, the transfer of zinc from Zn7-MT to apo-CA
was slow (Figure 32). Interestingly, the presence of Proteome further slowed down the reaction
between Zn7-MT and apo-CA (Figure 32). The reaction with denatured apo-CA produced similar
slow reconstitution. A zinc transfer equilibrium (Reaction 60) or ternary adduct formation
(Reaction 62) between Proteome via its sulfhydryl ligands and Zn7-MT might account for the
slow reaction of apo-CA and Zn7-MT in the presence of Proteome. To examine the putative
equilibrium between Proteomic sulfhydryl ligands and Zn7-MT, the reaction of apo-CA and Zn7MT was repeated in the presence Proteome which was pre-treated with N-ethylmaleimide
(NEM). Pre-treatment of Proteome with NEM resulted in a dramatic increase in the rate of ZnCA reconstitution (Figure 33), confirming the interaction between Proteomic thiolate ligands
and Zn7-MT, that might explain their negative effect on the reaction rate. To further probe the
equilibrium, Proteome and Zn7-MT were incubated and the re-distribution of zinc was
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quantified. Following incubation, a significant transfer of zinc from metallothionein to
Proteome was observed (Figure 34 and Table 1). When the Proteome fraction was separated
from the metallothionein fraction using a 10K molecular weight cut-off filter and subsequently
reacted with TSQ, a rapid fluorescence enhancement at 470 nm was exhibited, confirming that
excess zinc associated with Proteome and transferred from Zn7-MT was adventitiously bound as
Proteome-S•Zn, but not in the form of ternary adduct, Proteome-S•Zn7-MT, because TSQ does
not show any reactivity with metallothionein-bound zinc. These results clearly indicated that
metallothionein potentially plays an important role in zinc trafficking and in the synthesis of
native Zn-proteins by transferring its bound zinc to pre-cursor apo-Proteins via the formation of
Proteome•Zn.
Next, we investigated if glutathione has any impact on proteome- and/or metallothioneinmediated Zn-CA reformation, and if it plays a central role in cellular zinc trafficking. As
mentioned earlier, glutathione has a moderate zinc binding affinity with stability constant of
104-5 [85]. However, cells maintain a relatively high concentration of glutathione, namely 1 – 10
mM, under basal condition, that primarily acts as an anti-oxidant via its thiol group and thus
protects cells from damage caused by reactive oxygen species and reactive metabolites of
xenobiotics [104 - 106].
The presence of 1 mM glutathione (GSH) slowed down the reaction of apo-CA and Zn2+ to
regenerate Zn-CA, implying that glutathione mediated the transfer of zinc to apo-CA (Reactions
65 and 66). Surprisingly, glutathione caused an increase of the Proteome-mediated Zn-CA
reconstitution rate (Figure 36). Apparently, an equilibrium had been established between
Proteome-S•Zn and GSH, which resulted the generation of GS-Zn (Reactions 69-70). Finally, zinc
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from GS-Zn was transferred to apo-CA in a faster rate, instead of a slow transfer from
Proteome-S•Zn (Reaction 71). In addition, when the low molecular weight (LMW) fraction
isolated from the cell lysate of LLC-PK1 cells under basal condition was added to the high
molecular weight (HMW) Proteome fraction of the same lysate, a dramatic enhancement of ZnCA reconstitution, relative to that in the presence of HMW fraction only, was observed (Figure
37). This result further confirmed that glutathione, present in the LMW fraction, caused the
rate enhancement of Proteome-mediated Zn-CA regeneration. A similar rate enhancement was
exhibited when 1 mM exogenous glutathione was added to the same HMW Proteome fraction
(Figure 37). These results further supported the role of glutathione in Proteome-mediated ZnCA reformation.
Glutathione facilitated metallothionein-mediated Zn-CA reconstitution (Figure 38), suggesting
the formation of an intermediate, GS-Zn7-MT, (Reaction 77-79) that may have increased the
rate of transfer of zinc from Zn7-MT to apo-CA. Glutathione further enhanced the kinetics of ZnCA regeneration when both Proteome and Zn7-MT were present in the reaction (Figure 38). The
greater rate enhancement implied that glutathione prevented adduct formation between Zn 7MT and Proteome, and instead, formed a complex, GS-Zn7-MT, that eventually transferred zinc
to apo-CA at a faster rate. The formation of GS-Zn7-MT, resulting from the association of GSH
with one of the crevices in the α-domain of Zn7-MT has been reported in a previous study [107].
Having shown that glutathione has a significant impact on in vitro zinc trafficking in the
presence of Proteome and/or metallothionein, we then studied the effect of inhibition of
cellular glutathione synthesis on zinc trafficking in vivo. To inhibit glutathione synthesis, LLC-PK1
cells were treated with buthionine sulfoximine (BSO), a small molecule that inhibits the
154

necessary enzyme, gamma-glutamylcysteine synthetase, from catalyzing the first step of
cellular glutathione synthesis and thereby diminishes the cellular level of glutathione [108].
Treatment of LLC-PK1 cells with 100 µM BSO for 24 hours did not affect the proteomic
sulfhydryl content, but almost completely abolished the low molecular weight sulfhydryl
content, including glutathione while having only a marginal impact on cell viability.
When BSO-treated cells were reacted with TSQ, a rapid increase of 470-475 nm fluorescence
was observed, as opposed to untreated cells, which exhibited a much slower and smaller
increase of 470-475 nm fluorescence (Figure 41). TSQ has been reported to generate ternary
adducts, TSQ-Zn-Proteins, with native Zn-Proteins accompanied by a slow increase of 470-475
nm fluorescence [76-78]. It forms ternary complexes, Proteome•Zn-TSQ with non-specifically
bound proteomic zinc, Proteome•Zn, but with a rapid increase of fluorescence at 470-475 nm
[33]. Therefore, the experiment with BSO-treated cells indicated that the treatment caused a
greater accumulation of cellular zinc adventitiously bound to Proteome as Proteome•Zn, which
would have otherwise remained bound to cellular glutathione under basal conditions. The
apparent accumulation of Proteome•Zn following inhibition of glutathione synthesis implied
that under basal condition, a significant fraction of cellular labile zinc is bound by glutathione,
which mediates steady state zinc trafficking by transferring its bound zinc to pre-cursor apoProteins to generate native Zn-Proteins. When GSH was depleted, much larger concentrations
of labile Zn2+ accumulated in the Proteome as Proteome•Zn and some Zn-MT (Figure 43).
These larger concentrations were then hypothesized to become kinetically and
thermodynamically competent to supply Zn2+ for the constitution of Zn-proteins from apoprotein precursors.
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Similar fluorescence enhancement was observed when Proteome isolated from BSO-treated
cells was reacted with TSQ, relative to control Proteome (Figure 42). This experiment further
supported the conclusion that non-specifically bound proteomic zinc, Proteome•Zn had been
generated following glutathione inhibition. That cells proliferated normally even after inhibition
of glutathione synthesis indicated that the accumulated Proteome•Zn served as one of the
major sources of zinc for the synthesis of native Zn-Proteins.
As determined by Sephadex G-75 chromatography, Proteome collected from BSO-treated cells
contained a much larger zinc content, compared with non-treated control cell Proteome,
supporting the results of the TSQ reactions with cells and isolated Proteome. In total, BSOtreated cells contained as much as 2.1 times of zinc content of the same number of untreated
cells. Along with the increase in proteomic zinc, BSO treatment induced a sizeable pool of
metallothionein zinc as well, inferring that the increase of cellular zinc following glutathione
synthesis inhibition, apparently, upregulated metallothionein expression. Seemingly, preventing
glutathione synthesis caused an upregulation of cellular ZIP transporter activity that in turn
resulted in a greater uptake of extracellular zinc, leading to induced metallothionein synthesis
and the increase of proteomic zinc as Proteome•Zn.
As expected, the reaction of apo-CA with Proteome isolated from BSO-treated cells resulted in
a dramatic increase in rate and extent of Zn-CA reconstitution, relative to control cell Proteome
(Figure 44), confirming the presence of the much higher zinc content associated with BSOtreated Proteome as in the form of Proteome•Zn. The addition of 1 mM glutathione to BSO-
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treated Proteome did not change the extent of the reaction, which had gone to completion, but
further enhanced the rate of reaction significantly (Figure 45).
This experiment further supported our hypothesis that glutathione plays a crucial role in
cellular zinc trafficking to produce native Zn-Proteins. However, the fact that cells survived and
proliferated normally in the face of a greatly reduced concentration of cellular glutathione
indicated that the increased amount of non-specifically bound proteomic zinc as Proteome•Zn
and metallothionein zinc (Zn7-MT) could also serve as primary sources of zinc to make native
Zn-Proteins and satisfy the need of proliferative cells for Zn-Proteins.
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In summary, according to the experiments described in this thesis, the mechanism of cellular
zinc trafficking leading to the formation of native Zn-Proteins does not involve the straightforward transfer of zinc from one particular cellular component or chaperone to apo-Proteins.
Instead, trafficking occurs through a complex interconnected pathway that primarily includes
proteomic non-specific zinc binding sites, metallothionein and glutathione, and thus can be
depicted by the following schematic diagram.
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